JP2008125435A - Gel-forming composition, and gel containing composition - Google Patents
Gel-forming composition, and gel containing composition Download PDFInfo
- Publication number
- JP2008125435A JP2008125435A JP2006314063A JP2006314063A JP2008125435A JP 2008125435 A JP2008125435 A JP 2008125435A JP 2006314063 A JP2006314063 A JP 2006314063A JP 2006314063 A JP2006314063 A JP 2006314063A JP 2008125435 A JP2008125435 A JP 2008125435A
- Authority
- JP
- Japan
- Prior art keywords
- gel
- weight
- ratio
- forming composition
- gum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 70
- 235000010491 tara gum Nutrition 0.000 claims abstract description 80
- 239000000213 tara gum Substances 0.000 claims abstract description 80
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 77
- 239000005017 polysaccharide Substances 0.000 claims abstract description 77
- 230000009747 swallowing Effects 0.000 claims abstract description 67
- 229920001285 xanthan gum Polymers 0.000 claims abstract description 64
- 235000010493 xanthan gum Nutrition 0.000 claims abstract description 64
- 239000000230 xanthan gum Substances 0.000 claims abstract description 64
- 229940082509 xanthan gum Drugs 0.000 claims abstract description 64
- 239000004480 active ingredient Substances 0.000 claims abstract description 46
- 239000003125 aqueous solvent Substances 0.000 claims abstract description 29
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 17
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 17
- 229930003231 vitamin Natural products 0.000 claims abstract description 14
- 235000013343 vitamin Nutrition 0.000 claims abstract description 14
- 239000011782 vitamin Substances 0.000 claims abstract description 14
- 229940088594 vitamin Drugs 0.000 claims abstract description 14
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 13
- 239000004615 ingredient Substances 0.000 claims abstract description 10
- 150000004676 glycans Chemical class 0.000 claims abstract 9
- 230000008719 thickening Effects 0.000 claims description 52
- 235000012054 meals Nutrition 0.000 claims description 36
- 239000003795 chemical substances by application Substances 0.000 claims description 17
- 238000005259 measurement Methods 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 10
- 238000004519 manufacturing process Methods 0.000 claims description 9
- 238000002156 mixing Methods 0.000 claims description 9
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 9
- 239000002831 pharmacologic agent Substances 0.000 claims description 8
- 235000000346 sugar Nutrition 0.000 claims description 7
- 150000001720 carbohydrates Chemical class 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 5
- 235000013305 food Nutrition 0.000 abstract description 40
- 239000006185 dispersion Substances 0.000 abstract description 7
- 239000002562 thickening agent Substances 0.000 abstract description 2
- 150000003722 vitamin derivatives Chemical class 0.000 abstract description 2
- 239000000499 gel Substances 0.000 description 131
- 150000004804 polysaccharides Chemical class 0.000 description 68
- 238000003860 storage Methods 0.000 description 29
- 239000011572 manganese Substances 0.000 description 20
- 235000015110 jellies Nutrition 0.000 description 17
- 239000008274 jelly Substances 0.000 description 17
- 230000035882 stress Effects 0.000 description 16
- 235000018102 proteins Nutrition 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- 210000003800 pharynx Anatomy 0.000 description 12
- 230000007423 decrease Effects 0.000 description 9
- 239000000843 powder Substances 0.000 description 9
- 229920002472 Starch Polymers 0.000 description 8
- 230000008859 change Effects 0.000 description 8
- 238000004132 cross linking Methods 0.000 description 8
- 238000007710 freezing Methods 0.000 description 8
- 230000008014 freezing Effects 0.000 description 8
- 229920001353 Dextrin Polymers 0.000 description 7
- 239000004375 Dextrin Substances 0.000 description 7
- 229920002907 Guar gum Polymers 0.000 description 7
- 230000015572 biosynthetic process Effects 0.000 description 7
- 235000019425 dextrin Nutrition 0.000 description 7
- -1 fercellan Polymers 0.000 description 7
- 235000010417 guar gum Nutrition 0.000 description 7
- 239000000665 guar gum Substances 0.000 description 7
- 229960002154 guar gum Drugs 0.000 description 7
- 229920000591 gum Polymers 0.000 description 7
- 235000002639 sodium chloride Nutrition 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 235000019698 starch Nutrition 0.000 description 7
- 208000019505 Deglutition disease Diseases 0.000 description 6
- 229920000926 Galactomannan Polymers 0.000 description 6
- 229920000161 Locust bean gum Polymers 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 6
- 235000010420 locust bean gum Nutrition 0.000 description 6
- 239000000711 locust bean gum Substances 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 6
- 108010010803 Gelatin Proteins 0.000 description 5
- 235000013361 beverage Nutrition 0.000 description 5
- 239000003925 fat Substances 0.000 description 5
- 235000019197 fats Nutrition 0.000 description 5
- 239000008273 gelatin Substances 0.000 description 5
- 229920000159 gelatin Polymers 0.000 description 5
- 235000019322 gelatine Nutrition 0.000 description 5
- 235000011852 gelatine desserts Nutrition 0.000 description 5
- 239000008107 starch Substances 0.000 description 5
- 238000010257 thawing Methods 0.000 description 5
- OMDQUFIYNPYJFM-XKDAHURESA-N (2r,3r,4s,5r,6s)-2-(hydroxymethyl)-6-[[(2r,3s,4r,5s,6r)-4,5,6-trihydroxy-3-[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@H](O)[C@H](O)O1 OMDQUFIYNPYJFM-XKDAHURESA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 229920000858 Cyclodextrin Polymers 0.000 description 4
- 241000287828 Gallus gallus Species 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 235000010469 Glycine max Nutrition 0.000 description 4
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 4
- 208000002720 Malnutrition Diseases 0.000 description 4
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 4
- 244000046052 Phaseolus vulgaris Species 0.000 description 4
- 108010046377 Whey Proteins Proteins 0.000 description 4
- 102000007544 Whey Proteins Human genes 0.000 description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 4
- 235000010418 carrageenan Nutrition 0.000 description 4
- 229920001525 carrageenan Polymers 0.000 description 4
- 239000000679 carrageenan Substances 0.000 description 4
- 229940113118 carrageenan Drugs 0.000 description 4
- 235000013330 chicken meat Nutrition 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 238000001879 gelation Methods 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 238000010298 pulverizing process Methods 0.000 description 4
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 235000021119 whey protein Nutrition 0.000 description 4
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 4
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 3
- 241000237519 Bivalvia Species 0.000 description 3
- 241001474374 Blennius Species 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 3
- 244000068988 Glycine max Species 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 3
- 240000007594 Oryza sativa Species 0.000 description 3
- 235000007164 Oryza sativa Nutrition 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 235000021307 Triticum Nutrition 0.000 description 3
- 241000209140 Triticum Species 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 235000010419 agar Nutrition 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 235000020639 clam Nutrition 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 235000013601 eggs Nutrition 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 125000000311 mannosyl group Chemical group C1([C@@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 3
- 229920001542 oligosaccharide Polymers 0.000 description 3
- 150000002482 oligosaccharides Chemical class 0.000 description 3
- 235000009566 rice Nutrition 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000000052 vinegar Substances 0.000 description 3
- 235000021419 vinegar Nutrition 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- FTOAOBMCPZCFFF-UHFFFAOYSA-N 5,5-diethylbarbituric acid Chemical compound CCC1(CC)C(=O)NC(=O)NC1=O FTOAOBMCPZCFFF-UHFFFAOYSA-N 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- 239000004382 Amylase Substances 0.000 description 2
- 102000013142 Amylases Human genes 0.000 description 2
- 108010065511 Amylases Proteins 0.000 description 2
- 206010003504 Aspiration Diseases 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 229920002101 Chitin Polymers 0.000 description 2
- 229920001661 Chitosan Polymers 0.000 description 2
- 244000205754 Colocasia esculenta Species 0.000 description 2
- 235000006481 Colocasia esculenta Nutrition 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- 239000004278 EU approved seasoning Substances 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 244000017020 Ipomoea batatas Species 0.000 description 2
- 235000002678 Ipomoea batatas Nutrition 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
- 229920002774 Maltodextrin Polymers 0.000 description 2
- 239000005913 Maltodextrin Substances 0.000 description 2
- 244000070406 Malus silvestris Species 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 208000003286 Protein-Energy Malnutrition Diseases 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 2
- 240000004584 Tamarindus indica Species 0.000 description 2
- 235000004298 Tamarindus indica Nutrition 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 229940023476 agar Drugs 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 235000019418 amylase Nutrition 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 235000008452 baby food Nutrition 0.000 description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 2
- 230000000975 bioactive effect Effects 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 229940077731 carbohydrate nutrients Drugs 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 235000013365 dairy product Nutrition 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 235000019441 ethanol Nutrition 0.000 description 2
- 235000019688 fish Nutrition 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 235000011194 food seasoning agent Nutrition 0.000 description 2
- 229930182830 galactose Natural products 0.000 description 2
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 2
- 238000005227 gel permeation chromatography Methods 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 229960002989 glutamic acid Drugs 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229940035034 maltodextrin Drugs 0.000 description 2
- 230000018984 mastication Effects 0.000 description 2
- 238000010077 mastication Methods 0.000 description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 235000018343 nutrient deficiency Nutrition 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 229920001592 potato starch Polymers 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 235000020826 protein-energy malnutrition Nutrition 0.000 description 2
- 235000014102 seafood Nutrition 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- 150000005846 sugar alcohols Chemical class 0.000 description 2
- 230000009469 supplementation Effects 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 239000000811 xylitol Substances 0.000 description 2
- 235000010447 xylitol Nutrition 0.000 description 2
- 229960002675 xylitol Drugs 0.000 description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 2
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 1
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- HOMROMWVNDUGRI-RVZXSAGBSA-N (2s)-2-aminopentanedioic acid;(2s)-2,6-diaminohexanoic acid Chemical compound NCCCC[C@H](N)C(O)=O.OC(=O)[C@@H](N)CCC(O)=O HOMROMWVNDUGRI-RVZXSAGBSA-N 0.000 description 1
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 description 1
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-GASJEMHNSA-N 2-amino-2-deoxy-D-galactopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@H](O)[C@@H]1O MSWZFWKMSRAUBD-GASJEMHNSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 244000291564 Allium cepa Species 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 241000512259 Ascophyllum nodosum Species 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 208000000412 Avitaminosis Diseases 0.000 description 1
- 235000000832 Ayote Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241001107116 Castanospermum australe Species 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 241000555825 Clupeidae Species 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- 241001149724 Cololabis adocetus Species 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 241000544061 Cuculus canorus Species 0.000 description 1
- 244000241257 Cucumis melo Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- 241000219122 Cucurbita Species 0.000 description 1
- 235000009854 Cucurbita moschata Nutrition 0.000 description 1
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 description 1
- 235000003392 Curcuma domestica Nutrition 0.000 description 1
- 244000008991 Curcuma longa Species 0.000 description 1
- 229920002558 Curdlan Polymers 0.000 description 1
- 239000001879 Curdlan Substances 0.000 description 1
- AEMOLEFTQBMNLQ-DTEWXJGMSA-N D-Galacturonic acid Natural products O[C@@H]1O[C@H](C(O)=O)[C@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-DTEWXJGMSA-N 0.000 description 1
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- WHUUTDBJXJRKMK-GSVOUGTGSA-N D-glutamic acid Chemical compound OC(=O)[C@H](N)CCC(O)=O WHUUTDBJXJRKMK-GSVOUGTGSA-N 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- AANLCWYVVNBGEE-IDIVVRGQSA-L Disodium inosinate Chemical compound [Na+].[Na+].O[C@@H]1[C@H](O)[C@@H](COP([O-])([O-])=O)O[C@H]1N1C(NC=NC2=O)=C2N=C1 AANLCWYVVNBGEE-IDIVVRGQSA-L 0.000 description 1
- 208000030814 Eating disease Diseases 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 208000019454 Feeding and Eating disease Diseases 0.000 description 1
- PMVSDNDAUGGCCE-TYYBGVCCSA-L Ferrous fumarate Chemical compound [Fe+2].[O-]C(=O)\C=C\C([O-])=O PMVSDNDAUGGCCE-TYYBGVCCSA-L 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 102000013382 Gelatinases Human genes 0.000 description 1
- 108010026132 Gelatinases Proteins 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- 229920002581 Glucomannan Polymers 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229920000569 Gum karaya Polymers 0.000 description 1
- 229920002488 Hemicellulose Polymers 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- 206010021135 Hypovitaminosis Diseases 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- 241000758791 Juglandaceae Species 0.000 description 1
- QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 description 1
- SHZGCJCMOBCMKK-PQMKYFCFSA-N L-Fucose Natural products C[C@H]1O[C@H](O)[C@@H](O)[C@@H](O)[C@@H]1O SHZGCJCMOBCMKK-PQMKYFCFSA-N 0.000 description 1
- FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- 239000004158 L-cystine Substances 0.000 description 1
- 235000019393 L-cystine Nutrition 0.000 description 1
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 1
- 125000002066 L-histidyl group Chemical group [H]N1C([H])=NC(C([H])([H])[C@](C(=O)[*])([H])N([H])[H])=C1[H] 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 229930195722 L-methionine Natural products 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- 241000218652 Larix Species 0.000 description 1
- 235000005590 Larix decidua Nutrition 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 235000015429 Mirabilis expansa Nutrition 0.000 description 1
- 244000294411 Mirabilis expansa Species 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 239000004368 Modified starch Substances 0.000 description 1
- 206010061296 Motor dysfunction Diseases 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 235000010676 Ocimum basilicum Nutrition 0.000 description 1
- 240000007926 Ocimum gratissimum Species 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 241000237503 Pectinidae Species 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 244000203593 Piper nigrum Species 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- 244000088415 Raphanus sativus Species 0.000 description 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 241000269851 Sarda sarda Species 0.000 description 1
- 241000269821 Scombridae Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 244000040738 Sesamum orientale Species 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000009337 Spinacia oleracea Nutrition 0.000 description 1
- 244000300264 Spinacia oleracea Species 0.000 description 1
- 241000934878 Sterculia Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- 241001504592 Trachurus trachurus Species 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 241001504501 Troglodytes Species 0.000 description 1
- 235000011453 Vigna umbellata Nutrition 0.000 description 1
- 240000001417 Vigna umbellata Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 241000589636 Xanthomonas campestris Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 229960003767 alanine Drugs 0.000 description 1
- IAJILQKETJEXLJ-RSJOWCBRSA-N aldehydo-D-galacturonic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-RSJOWCBRSA-N 0.000 description 1
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- FYGDTMLNYKFZSV-DZOUCCHMSA-N alpha-D-Glcp-(1->4)-alpha-D-Glcp-(1->4)-D-Glcp Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)O[C@H](O[C@@H]2[C@H](OC(O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-DZOUCCHMSA-N 0.000 description 1
- GZCGUPFRVQAUEE-UHFFFAOYSA-N alpha-D-galactose Natural products OCC(O)C(O)C(O)C(O)C=O GZCGUPFRVQAUEE-UHFFFAOYSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-WAXACMCWSA-N alpha-D-glucuronic acid Chemical compound O[C@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-WAXACMCWSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-ASMJPISFSA-N alpha-maltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-ASMJPISFSA-N 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 239000000043 antiallergic agent Substances 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 229940030600 antihypertensive agent Drugs 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000000164 antipsychotic agent Substances 0.000 description 1
- 235000021016 apples Nutrition 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 229960005261 aspartic acid Drugs 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- 229960002319 barbital Drugs 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- AEMOLEFTQBMNLQ-UHFFFAOYSA-N beta-D-galactopyranuronic acid Natural products OC1OC(C(O)=O)C(O)C(O)C1O AEMOLEFTQBMNLQ-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-RWOPYEJCSA-N beta-D-mannose Chemical compound OC[C@H]1O[C@@H](O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-RWOPYEJCSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 235000021279 black bean Nutrition 0.000 description 1
- 235000013614 black pepper Nutrition 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 238000005282 brightening Methods 0.000 description 1
- 235000021329 brown rice Nutrition 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 150000001765 catechin Chemical class 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- 150000001783 ceramides Chemical class 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 229940109248 cromoglycate Drugs 0.000 description 1
- IMZMKUWMOSJXDT-UHFFFAOYSA-N cromoglycic acid Chemical compound O1C(C(O)=O)=CC(=O)C2=C1C=CC=C2OCC(O)COC1=CC=CC2=C1C(=O)C=C(C(O)=O)O2 IMZMKUWMOSJXDT-UHFFFAOYSA-N 0.000 description 1
- 235000003373 curcuma longa Nutrition 0.000 description 1
- 235000019316 curdlan Nutrition 0.000 description 1
- 229940078035 curdlan Drugs 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 150000008266 deoxy sugars Chemical class 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 235000021185 dessert Nutrition 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 229940124568 digestive agent Drugs 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 229960000520 diphenhydramine Drugs 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 description 1
- 235000013890 disodium inosinate Nutrition 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 230000007914 freezing tolerance Effects 0.000 description 1
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 description 1
- 229940107187 fructooligosaccharide Drugs 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000008717 functional decline Effects 0.000 description 1
- 235000021255 galacto-oligosaccharides Nutrition 0.000 description 1
- 150000003271 galactooligosaccharides Chemical class 0.000 description 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 235000010492 gellan gum Nutrition 0.000 description 1
- 239000000216 gellan gum Substances 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 229940046240 glucomannan Drugs 0.000 description 1
- 150000002302 glucosamines Chemical class 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 229960002449 glycine Drugs 0.000 description 1
- 150000002337 glycosamines Chemical class 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 229960001680 ibuprofen Drugs 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 description 1
- 235000010494 karaya gum Nutrition 0.000 description 1
- 239000000231 karaya gum Substances 0.000 description 1
- 229940039371 karaya gum Drugs 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000000832 lactitol Substances 0.000 description 1
- 235000010448 lactitol Nutrition 0.000 description 1
- 229960003451 lactitol Drugs 0.000 description 1
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- AGBQKNBQESQNJD-UHFFFAOYSA-M lipoate Chemical compound [O-]C(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-M 0.000 description 1
- 235000019136 lipoic acid Nutrition 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000020640 mackerel Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 238000010309 melting process Methods 0.000 description 1
- 229960000582 mepyramine Drugs 0.000 description 1
- YECBIJXISLIIDS-UHFFFAOYSA-N mepyramine Chemical compound C1=CC(OC)=CC=C1CN(CCN(C)C)C1=CC=CC=N1 YECBIJXISLIIDS-UHFFFAOYSA-N 0.000 description 1
- 229960004452 methionine Drugs 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000013536 miso Nutrition 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 239000006082 mold release agent Substances 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 235000013923 monosodium glutamate Nutrition 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- KJONHKAYOJNZEC-UHFFFAOYSA-N nitrazepam Chemical compound C12=CC([N+](=O)[O-])=CC=C2NC(=O)CN=C1C1=CC=CC=C1 KJONHKAYOJNZEC-UHFFFAOYSA-N 0.000 description 1
- 229960001454 nitrazepam Drugs 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 210000003254 palate Anatomy 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000009894 physiological stress Effects 0.000 description 1
- 235000020098 plum wine Nutrition 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 235000012015 potatoes Nutrition 0.000 description 1
- 235000008476 powdered milk Nutrition 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 235000021075 protein intake Nutrition 0.000 description 1
- 235000011962 puddings Nutrition 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- 235000015136 pumpkin Nutrition 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 229940100486 rice starch Drugs 0.000 description 1
- 229940085605 saccharin sodium Drugs 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 235000019512 sardine Nutrition 0.000 description 1
- 235000020637 scallop Nutrition 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- 229940125724 sleeping drug Drugs 0.000 description 1
- 229940073490 sodium glutamate Drugs 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000003687 soy isoflavones Nutrition 0.000 description 1
- 235000013322 soy milk Nutrition 0.000 description 1
- 235000013555 soy sauce Nutrition 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000010902 straw Substances 0.000 description 1
- 235000021012 strawberries Nutrition 0.000 description 1
- WPLOVIFNBMNBPD-ATHMIXSHSA-N subtilin Chemical compound CC1SCC(NC2=O)C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(C(C)CC)C(=O)NC(=C)C(=O)NC(CCCCN)C(O)=O)CSC(C)C2NC(=O)C(CC(C)C)NC(=O)C1NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C1NC(=O)C(=C/C)/NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C2NC(=O)CNC(=O)C3CCCN3C(=O)C(NC(=O)C3NC(=O)C(CC(C)C)NC(=O)C(=C)NC(=O)C(CCC(O)=O)NC(=O)C(NC(=O)C(CCCCN)NC(=O)C(N)CC=4C5=CC=CC=C5NC=4)CSC3)C(C)SC2)C(C)C)C(C)SC1)CC1=CC=CC=C1 WPLOVIFNBMNBPD-ATHMIXSHSA-N 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 229960002663 thioctic acid Drugs 0.000 description 1
- 239000012929 tonicity agent Substances 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- 235000013976 turmeric Nutrition 0.000 description 1
- 235000000112 undernutrition Nutrition 0.000 description 1
- 229960004295 valine Drugs 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 208000030401 vitamin deficiency disease Diseases 0.000 description 1
- 235000020234 walnut Nutrition 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 229940100445 wheat starch Drugs 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
Images
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Jellies, Jams, And Syrups (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
本発明は、ゲルの形態を保持しつつ、応力の作用により大きく変形し、嚥下食に有用なゲルを形成するのに適したゲル形成性組成物及びこの組成物を含有するゲル、並びにそれらの製造方法に関する。 The present invention relates to a gel-forming composition suitable for forming a gel useful for swallowing, which is largely deformed by the action of stress while maintaining the form of the gel, and a gel containing this composition, and their It relates to a manufacturing method.
摂食においては、食物の咀嚼や、舌と口蓋で押しつぶすなどの処理がなされた後、食物の飲み込み(嚥下)の準備である食塊形成がなされる。食塊が口腔の後方(咽頭)に移送される際、嚥下反射により、食塊は0.5秒ほどで咽頭を通過する。咽頭は、嚥下の際にのみ食塊の通路となるが、この通路の切り替えに障害(嚥下障害)が生じると、誤って食塊が肺に流入する(誤嚥)などの危険性が高くなり、肺炎の原因となり得る。 In eating, after processing such as mastication of food and crushing with the tongue and palate, a bolus is formed as preparation for swallowing food (swallowing). When the bolus is transferred to the back of the mouth (pharynx), the bolus passes through the pharynx in about 0.5 seconds due to swallowing reflexes. The pharynx becomes a bolus passage only during swallowing, but if there is an obstacle in switching this passage (dysphagia), the risk of the bolus accidentally flowing into the lungs (aspiration) increases. Can cause pneumonia.
さらに、嚥下障害が引き金となり、寝たきりになる場合がある。嚥下機能が低下すると、食事量が減少し、かつ偏った食事になり、糖質やたんぱく質、脂肪などの栄養成分の摂取量が激減し、特定栄養成分の欠乏症(例えば、骨粗鬆症、運動機能障害など)やたんぱく質・エネルギー低栄養状態(Protein Energy Malnutrition,PEM)などに至る傾向にある。PEMは慢性的なエネルギー不足やタンパク質の摂取不足に加え、疾患や損傷などの生理的ストレスが生じたときに起こりやすいと言われている。特に、高齢者がPEMなどに陥ると、体力が落ち、寝たきり状態になりやすい。さらに、疾患治療に多大な影響を受け、高齢者自身が危険な状態に晒されるだけでなく、医療の経済面(例えば、医療費の増大など)及び経営面(例えば、入院の長期化など)などにも問題が生じ得る。 In addition, dysphagia can trigger and bedridden. When swallowing function declines, the amount of meal decreases and the diet becomes biased, intake of nutrients such as carbohydrates, proteins, and fats drastically decreases, and deficiencies of specific nutrients (eg, osteoporosis, motor dysfunction, etc.) ) And protein / energy undernutrition (Protein Energy Malnutrition, PEM). PEM is said to occur easily when physiological stress such as disease or injury occurs in addition to chronic energy deficiency and protein intake deficiency. In particular, when an elderly person falls into PEM or the like, his / her physical strength declines and he / she tends to be bedridden. In addition, not only is the elderly affected themselves at risk, but also the medical economics (eg, increased medical costs) and management (eg, prolonged hospitalization). Problems can also arise.
そこで、特定栄養成分の欠乏症やPEMなどの嚥下障害が原因となる疾病の予防、早期治療に重要となるのが、不足栄養成分の補給を担う嚥下食である。 Therefore, it is important to prevent swallowing such as deficiency of specific nutritional component and dysphagia such as PEM and early treatment.
嚥下食の基材として、昨今、多糖類が使用される場合が多い。多糖類は、独特のレオロジー特性(粘弾性やテクスチャーなど)を有し、粘性、安定性などを与える。しかし、多糖類を単独で用いても、嚥下食として要求されるレオロジー特性を満足させることは難しく、現状として、多糖類どうしを組み合わせて、それぞれの多糖類が有するレオロジー特性などに相乗効果をもたらしている。 Recently, polysaccharides are often used as a base material for swallowing meals. Polysaccharides have unique rheological properties (such as viscoelasticity and texture) and give viscosity, stability and the like. However, even if polysaccharides are used alone, it is difficult to satisfy the rheological characteristics required for swallowing meals. Currently, combining polysaccharides brings synergistic effects on the rheological characteristics of each polysaccharide. ing.
これまでに多糖類の組み合わせで構成されている嚥下食として、例えば、特開2005−341848号公報(特許文献1)に、キサンタンガムと、ローカストビーンガム、グアーガム、タラガム、タマリンドガム又はカラギーナンの何れか1種とで構成される嚥下困難者用飲料粉末が提案されている。この嚥下困難者用飲料粉末は、水に溶解するとゾル状になるため、水分補給用として用いるのに適している。しかし、生理活性成分などの活性成分を添加すると、さらにゾル化が進み、栄養補給用としてこの嚥下困難者用飲料粉末を用いると、嚥下の際、喉への付着性が高くなる傾向がある。 Examples of swallowing meals that have been composed of a combination of polysaccharides so far include, for example, JP 2005-341848 A (Patent Document 1), xanthan gum, locust bean gum, guar gum, tara gum, tamarind gum, or carrageenan Beverage powder for persons with difficulty in swallowing composed of one kind has been proposed. Since this beverage powder for persons with difficulty in swallowing becomes sol when dissolved in water, it is suitable for use as a water replenisher. However, when an active ingredient such as a physiologically active ingredient is added, sol-formation further proceeds, and when this beverage powder for people with difficulty in swallowing is used for nutritional supplementation, the adhesion to the throat tends to increase during swallowing.
さらに、特開2000−191553号公報(特許文献2)では、タラガム及び/又はローカストビーンガムと、キサンタンガムとで構成された易嚥下補助組成物が開示され、嚥下時の喉への付着性が軽減され、また、粘度の経時安定性に優れている。この文献には、ゲル中におけるゲル化剤の割合は、0.1〜10重量%(特に0.5〜2重量%)であると記載されている。また、ガム混合物の食品への配合割合によって、形成されるゲル状構造の硬さを自由に嚥下に適した硬さに決定することができることも記載されている。しかし、この文献で用いられているタラガムでは、キサンタンガムとの組み合わせのゲル形成能は小さく、ゲルを形成するためには、比較的多くのタラガムを必要とする。 Furthermore, Japanese Patent Application Laid-Open No. 2000-191553 (Patent Document 2) discloses an easy swallowing assisting composition composed of tara gum and / or locust bean gum and xanthan gum, which reduces adhesion to the throat during swallowing. In addition, the viscosity is excellent in stability over time. This document describes that the ratio of the gelling agent in the gel is 0.1 to 10% by weight (particularly 0.5 to 2% by weight). It is also described that the hardness of the gel-like structure formed can be determined to a hardness suitable for swallowing according to the blending ratio of the gum mixture into the food. However, the tara gum used in this document has a small gel-forming ability in combination with xanthan gum, and a relatively large amount of tara gum is required to form a gel.
嚥下食の基材として汎用される多糖類は、分子間及び/又は分子内水素結合により、分子同士が会合して絡み合った構造、らせん状、ボール状などの複雑な構造をしている。そのため、多糖類をゲル化して、高い粘性を有し、かつ均質なゲルを得るには、ゲル形成過程において、過酷な加熱処理を必要とする場合が多い。特開2004−350680号公報(特許文献3)には、たん白質、ビタミン類を含有する咀嚼・嚥下困難者用食品が、特開2004−147639号公報(特許文献4)には、タンパク質で構成される成分、ビタミン類を含有する咀嚼・嚥下訓練食が提案されている。しかし、いずれも、ゲル形成過程で、増粘多糖類を熱水に溶解するなどの処理により、これらの成分は凝集・沈殿し、得られる食品の食感が悪くなる傾向がある。 Polysaccharides widely used as a base material for swallowing meal have a complicated structure such as a structure in which molecules are entangled by intermolecular and / or intramolecular hydrogen bonding, a spiral shape, a ball shape, or the like. Therefore, severe gelation is often required in the gel formation process in order to gel the polysaccharide and obtain a highly viscous and homogeneous gel. Japanese Patent Application Laid-Open No. 2004-350680 (Patent Document 3) discloses a food for a person with difficulty in chewing / swallowing containing protein and vitamins, and Japanese Patent Application Laid-Open No. 2004-147639 (Patent Document 4) is composed of a protein. Mastication and swallowing training foods that contain vitamins and other ingredients have been proposed. However, in any case, these components are aggregated and precipitated by a treatment such as dissolving the thickening polysaccharide in hot water during the gel formation process, and the texture of the obtained food tends to deteriorate.
熱変性や熱分解性の活性成分(例えば、タンパク質、ビタミン類など)を含有し、嚥下に好適な嚥下食を調製するには、嚥下食の基材がゲル形成能を有し、かつ低温度(又は非加熱)で溶解することが必要とされる。ゲル形成能を有し、低温度で溶解する多糖類としてゼラチンも知られている。しかし、ゼラチンゲルは、常温でゾル化し、またゼラチン水溶液が均質にゲル化するのに長時間要することなどから、ゼラチンは嚥下食の基材としては実用的ではない。 In order to prepare a swallow food suitable for swallowing containing an active ingredient (for example, protein, vitamins, etc.) that is heat-denatured or thermally decomposable, the base material of the swallow food has gel-forming ability and low temperature. It is required to dissolve (or unheated). Gelatin is also known as a polysaccharide that has gel-forming ability and dissolves at a low temperature. However, gelatin is not practical as a base material for swallowing foods because gelatin gels at room temperature and it takes a long time for an aqueous gelatin solution to gel uniformly.
そのため、低温条件下(又は非加熱条件下)であってもゲル形成能を有する多糖類で構成される嚥下食基材であって、ゲルの形態を保持しつつも、小さな応力で大きく変形する大変形性を有する嚥下に適したゲルを形成するための嚥下食基材が強く求められている。
従って、本発明の目的は、小さな応力で大変形するものの、ゲルの形態を保持し、嚥下に適したゲルを調製するのに適したゲル形成性組成物、その組成物を含有するゲル及びその製造方法を提供することにある。 Accordingly, an object of the present invention is to provide a gel-forming composition suitable for preparing a gel suitable for swallowing, which retains the gel shape, while undergoing large deformation under small stress, and a gel containing the composition and the gel It is to provide a manufacturing method.
本発明の他の目的は、構成成分である増粘多糖類が低濃度であっても、嚥下に適したゲルを形成可能なゲル形成性組成物、その組成物を含有するゲル及びその製造方法を提供することにある。 Another object of the present invention is to provide a gel-forming composition capable of forming a gel suitable for swallowing even when the thickening polysaccharide as a constituent component is at a low concentration, a gel containing the composition, and a method for producing the gel Is to provide.
本発明のさらに他の目的は、活性成分、特にタンパク質、ペプチド及びビタミンなどの熱で変性又は分解し得る成分を均一に含み、嚥下食の基材として有用なゲル形成性組成物、その組成物を含有するゲル及びその製造方法を提供することにある。 Still another object of the present invention is to provide a gel-forming composition useful as a base for swallowing foods, which uniformly contains active ingredients, particularly ingredients that can be denatured or decomposed by heat, such as proteins, peptides and vitamins. It is providing the gel containing this and its manufacturing method.
本発明者らは、前記課題を達成するため鋭意検討した結果、キサンタンガムとタラガムとの組み合わせにおいて、タラガムの分子量がゲル形成能に大きく影響すること、キサンタンガムと、高分子量のタラガムとを組み合わせると、増粘多糖類の濃度が低くても水性溶媒とでゲルを形成することができ、形成されるゲルは、ゲルの形態を保持しつつ、小さな応力に対して大きく変形する性質を有することを見いだし、本発明を完成した。 As a result of intensive studies to achieve the above-mentioned problems, the present inventors have found that in the combination of xanthan gum and tara gum, the molecular weight of tara gum greatly affects the gel-forming ability, and when xanthan gum and high molecular weight tara gum are combined, It has been found that gels can be formed with aqueous solvents even when the concentration of thickening polysaccharides is low, and the formed gels have the property of being greatly deformed by small stress while maintaining the gel form. The present invention has been completed.
すなわち、本発明のゲル形成性組成物は、少なくともキサンタンガムと高分子量のタラガムとで構成される組成物であって、タラガムの数平均分子量(Mn)は30万以上(例えば、40万以上)である。また、本発明のゲル形成性組成物は、動的粘弾性測定において、変形率に対する力学的正接損失(tanδ)の変曲点を、変形率が20〜50%の範囲に有し、かつ前記変曲点における力学的正接損失(tanδ)が0.1〜1であるゲルを形成する。特に、本発明では、高分子量で、かつ分子量の分散度が小さいタラガムを用いることで、増粘多糖類が少量であっても前記変形率及び力学的正接損失tanδを示すゲルを形成することができる。さらに本発明では、高分子量で、かつ分子量の分散度が小さいタラガムを用いることで、均質な三次元網目構造を有するゲルをも形成することができ、タラガムの数平均分子量(Mn)と重量平均分子量(Mw)との比(Mw/Mn)10以下(例えば、Mw/Mnが8以下)であってもよい。キサンタンガムとタラガムとの割合(重量比)は、前者/後者=10/90〜90/10程度、例えば、20/80〜85/15程度であってもよい。さらに、本発明のゲル形成性組成物は、保水剤(例えば、デキストリンなどの糖類)を含んでいてもよい。 That is, the gel-forming composition of the present invention is a composition composed of at least xanthan gum and high molecular weight tara gum, and the number average molecular weight (Mn) of the tara gum is 300,000 or more (for example, 400,000 or more). is there. Further, the gel-forming composition of the present invention has an inflection point of mechanical tangent loss (tan δ) with respect to the deformation rate in the range of 20 to 50% in the dynamic viscoelasticity measurement. A gel having a mechanical tangent loss (tan δ) at the inflection point of 0.1 to 1 is formed. In particular, in the present invention, by using tara gum having a high molecular weight and a low molecular weight dispersibility, a gel showing the deformation rate and the mechanical tangent loss tan δ can be formed even with a small amount of thickening polysaccharide. it can. Furthermore, in the present invention, by using tara gum having a high molecular weight and a low molecular weight dispersion, a gel having a homogeneous three-dimensional network structure can be formed, and the number average molecular weight (Mn) and weight average of tara gum The ratio (Mw / Mn) to the molecular weight (Mw) may be 10 or less (for example, Mw / Mn is 8 or less). The ratio (weight ratio) between xanthan gum and tara gum may be the former / the latter = about 10/90 to 90/10, for example, about 20/80 to 85/15. Furthermore, the gel-forming composition of the present invention may contain a water retention agent (for example, a saccharide such as dextrin).
さらに、本発明には、少なくとも前記ゲル形成性組成物及び水性溶媒で構成されるゲルも含まれる。このゲルは、動的粘弾性測定において、変形率に対する力学的正接損失(tanδ)の変曲点を、変形率20〜50%の範囲に有し、かつ変曲点における(tanδ)が0.1〜1であってもよい。前記増粘多糖類の割合は、0.1〜1重量%(例えば、0.2〜0.7重量%)であってもよい。また、前記ゲルは、増粘多糖類1重量部に対して0.1〜30重量部の割合で保水剤を含んでいてもよい。また、ゲル形成性組成物の割合が、0.5〜5重量%であってもよい。 Furthermore, the present invention includes a gel composed of at least the gel-forming composition and an aqueous solvent. This gel has an inflection point of the dynamic tangent loss (tan δ) with respect to the deformation rate in the range of 20 to 50% in the dynamic viscoelasticity measurement, and the (tan δ) at the inflection point is 0. 1-1 may be sufficient. The proportion of the thickening polysaccharide may be 0.1 to 1% by weight (for example, 0.2 to 0.7% by weight). Moreover, the said gel may contain the water retention agent in the ratio of 0.1-30 weight part with respect to 1 weight part of thickening polysaccharide. Moreover, 0.5-5 weight% may be sufficient as the ratio of a gel-forming composition.
前記ゲルは、活性成分(特に、タンパク質、ペプチド、ビタミンなど)を含む嚥下食として有用である。嚥下食としては、キサンタンガムとタラガムとの割合(重量比)が、前者/後者=25/75〜80/20であり、かつ増粘多糖類の割合が、0.3〜0.6重量%程度であってもよく、活性成分を、ゲル形成性組成物及び水性溶媒の全体100重量部に対して、0.001〜20重量部の割合で含んでいてもよい。なお、活性成分が生理活性成分である場合には、生理活性成分を、ゲル形成性組成物及び水性溶媒の全体100重量部に対して、1〜20重量部の割合で含有していてもよい。また、活性成分が薬理活性成分である場合には、薬理活性成分を、ゲル形成性組成物及び水性溶媒の全体100重量部に対して、0.001〜0.1重量部の割合で含有していてもよい。 The gel is useful as a swallowing meal containing active ingredients (particularly proteins, peptides, vitamins, etc.). As a swallowing meal, the ratio (weight ratio) of xanthan gum and tara gum is the former / the latter = 25 / 75-80 / 20, and the ratio of the thickening polysaccharide is about 0.3-0.6% by weight The active ingredient may be included in a ratio of 0.001 to 20 parts by weight with respect to 100 parts by weight of the total of the gel-forming composition and the aqueous solvent. In addition, when an active ingredient is a bioactive ingredient, you may contain the bioactive ingredient in the ratio of 1-20 weight part with respect to 100 weight part of the whole gel-forming composition and an aqueous solvent. . Further, when the active ingredient is a pharmacologically active ingredient, the pharmacologically active ingredient is contained in a proportion of 0.001 to 0.1 parts by weight with respect to 100 parts by weight of the entire gel-forming composition and aqueous solvent. It may be.
本発明には、前記ゲル形成性組成物と水性溶媒とを混合して前記ゲルを製造する方法及び前記ゲル形成性組成物と水性溶媒とを非加熱下で混合して前記ゲルを製造する方法も含まれる。さらに、保水剤及び活性成分から選択された少なくとも一種を混合して前記ゲルを製造する方法も含まれる。 The present invention includes a method for producing the gel by mixing the gel-forming composition and an aqueous solvent, and a method for producing the gel by mixing the gel-forming composition and an aqueous solvent without heating. Is also included. Furthermore, the method of manufacturing the said gel by mixing at least 1 type selected from the water retention agent and the active ingredient is also contained.
本発明には、キサンタンガムと、数平均分子量(Mn)が30万以上であるタラガムとを組み合わせた増粘多糖類で構成されるゲル形成性組成物を用いた水性ゲルにおいて、動的粘弾性測定において、変形率に対する力学的正接損失(tanδ)の変曲点を、変形率20〜50%、かつ前記変曲点における力学的正接損失(tanδ)を0.1〜1に調整する方法であって、増粘多糖類全体に対するキサンタンガムの割合が増加するにつれて、ゲル形成性組成物及び水性溶媒の全体に対する増粘多糖類の割合を増加させ、前記ゲルの前記変形率及び力学的正接損失(tanδ)を調整する方法も含まれる。 In the present invention, dynamic viscoelasticity measurement is performed in an aqueous gel using a gel-forming composition composed of a thickening polysaccharide in which xanthan gum and tara gum having a number average molecular weight (Mn) of 300,000 or more are combined. In this method, the inflection point of the mechanical tangent loss (tan δ) with respect to the deformation rate is adjusted to a deformation rate of 20 to 50%, and the mechanical tangent loss (tan δ) at the inflection point is adjusted to 0.1 to 1. As the ratio of xanthan gum to the total thickening polysaccharide increases, the ratio of the thickening polysaccharide to the total of the gel-forming composition and the aqueous solvent is increased, and the deformation rate and the mechanical tangent loss (tan δ) of the gel are increased. ) Is also included.
なお、「変形率に対する力学的正接損失(tanδ)の変曲点」とは、「ゲル構造の変化点」として表すことができ、「変形率に対する力学的正接損失(tanδ)の変曲点を、変形率20〜50%の範囲に有し、かつ変曲点におけるtanδが0.1〜1であるゲル」とは、「ゲル構造の変化点における変形率が20〜50%であり、かつ前記変化点における力学的正接損失(tanδ)が0.1〜1であるゲル」を意味する。 The “inflection point of the mechanical tangent loss (tan δ) with respect to the deformation rate” can be expressed as “the change point of the gel structure”. The gel having a deformation rate in the range of 20 to 50% and tan δ at the inflection point of 0.1 to 1 means that “the deformation rate at the change point of the gel structure is 20 to 50%, and It means a gel whose mechanical tangent loss (tan δ) at the change point is 0.1-1.
本発明では、ゲル形成性組成物が、少なくともキサンタンガムと高分子量のタラガムとで構成されているため、嚥下に好適な大変形性を有するフローゼリー状態のゲルを形成することができる。さらに、前記ゲル形成性組成物は、増粘多糖類が低濃度であっても、しかも非加熱条件下または低温下であってもゲル形成能を有するため、形成されるゲルは、特に、熱で変性又は分解し得る成分(タンパク質、ペプチド及びビタミンなど)を均質に含むことができ、嚥下食の基材に有用である。 In the present invention, since the gel-forming composition is composed of at least xanthan gum and high molecular weight tara gum, a gel in a flow jelly state having large deformability suitable for swallowing can be formed. Further, since the gel-forming composition has gel-forming ability even when the polysaccharide thickener is at a low concentration, and also under non-heated conditions or under low temperature, the gel formed is particularly Ingredients (proteins, peptides, vitamins, etc.) that can be denatured or degraded can be homogeneously contained and are useful as a base material for swallowing food.
[ゲル形成性組成物]
本発明のゲル形成性組成物は、少なくともキサンタンガムと特定のガラクトマンナンとで構成された増粘多糖類を含む。
[Gel-forming composition]
The gel-forming composition of the present invention contains a thickening polysaccharide composed of at least xanthan gum and a specific galactomannan.
キサンタンガムは、キサントモナス・キャンペストリス(Xanthomonas campestris)が菌体外に生産する多糖類であり、β−D−グルコースが(1→4)結合した主鎖と、この主鎖に、二個のD−マンノースとグルクロン酸とからなる側鎖が結合した高度に枝分かれした構造をしており、水溶液中では、二重らせん構造が会合して形成された高次構造をとる。キサンタンガムは、長い側鎖のために、冷水にも容易に溶解するが、単独ではゲル形成能を有さず、他の多糖類(例えば、ガラクトマンナンなど)と組み合わせるのが好ましい。本発明で用いるキサンタンガムは、特に制限されず、市販のキサンタンガムであってもよい。 Xanthan gum is a polysaccharide produced outside the cell by Xanthomonas campestris, and has a main chain in which β-D-glucose is (1 → 4) bonded, and two Ds on this main chain. -It has a highly branched structure in which side chains composed of mannose and glucuronic acid are combined, and in aqueous solution, it has a higher order structure formed by association of double helical structures. Xanthan gum dissolves easily in cold water due to its long side chain, but it does not have gel-forming ability alone, and is preferably combined with other polysaccharides (eg, galactomannan). The xanthan gum used in the present invention is not particularly limited and may be a commercially available xanthan gum.
ガラクトマンナンは、β−D−マンノースが(1→4)結合した主鎖に、側鎖としてα−D−ガラクトースが(1→6)結合した構造を有している。ガラクトマンナンは、分子鎖中のマンノースとガラクトースとの比率に応じて分類されている。例えば、タラガムは、マンノース単位/ガラクトース単位(モル比)が3/1である。言い換えれば、タラガムは、マンノース3分子に、ガラクトース1分子が分岐した構造をしている。なお、他のガラクトマンナンには、例えばローカストビーンガムやグアーガムなどがあり、ローカストビーンガムでは、マンノース単位/ガラクトース単位(モル比)=4/1、グアーガムでは、マンノース単位/ガラクトース単位(モル比)=2/1である。 Galactomannan has a structure in which α-D-galactose is (1 → 6) bonded as a side chain to a main chain in which β-D-mannose is bonded (1 → 4). Galactomannans are classified according to the ratio of mannose and galactose in the molecular chain. For example, tara gum has a mannose unit / galactose unit (molar ratio) of 3/1. In other words, tara gum has a structure in which one molecule of galactose is branched to three molecules of mannose. Other galactomannans include, for example, locust bean gum and guar gum. In locust bean gum, mannose unit / galactose unit (molar ratio) = 4/1, and in guar gum, mannose unit / galactose unit (molar ratio). = 2/1.
本発明では、タラガムを用いる。タラガムは、タラ(Cesalpinia spinosa)の種子の胚乳部から単離される多糖類である。タラガムは、水に可溶であるが、単独ではゲル形成能を有さないため、キサンタンガムと組み合わせてゲルを形成させるのが好ましい。より詳細には、タラガムなどのガラクトマンナンは、キサンタンガムと主鎖の構造が類似していることから、両者は分子鎖間で凝集、架橋し、主に水素結合を介して三次元網目構造を形成し、三次元網目構造の単位体積あたりの架橋数に応じ、ゲル化が可能となる。側鎖の少ないローカストビーンガムでは、キサンタンガムと会合して強固な網目構造を作り、弾力のあるゲルを形成する。一方、側鎖の多いタラガムでは、立体障害により、キサンタンガムとの間に架橋点が形成されにくいためか、キサンタンガムとタラガムとの組み合わせによるゲル形成能は決して大きいとは言えない。本発明者らは、低分子量成分をカットし、高分子量のタラガムとし、かつキサンタンガムと組み合わせることによりゲルが形成されることを見いだした。すなわち、キサンタンガムとタラガムとの組み合わせによるゲル形成能を向上させるために、高分子量のタラガムを用いることが有用であり、特に、高分子量でかつ分子量の分散度が小さいタラガムを用いることが有用である。ここで、高分子量のタラガムを用いると、キサンタンガムとで形成されるゲルの架橋領域が増加し、また、分子量の分散度の小さいタラガムを用いると、ゲルの三次元網目構造の均質性が増加する。本発明において、高分子量でかつ分子量の分散度の小さいタラガムを用いると、形成されるゲルの架橋領域を増加させることができ、かつゲルの三次元網目構造の均質性を増加させることができる。 In the present invention, tara gum is used. Tara gum is a polysaccharide isolated from the endosperm part of the seed of cod (Cesalpinia spinosa). Although tara gum is soluble in water, it does not have gel-forming ability by itself, so it is preferable to form a gel in combination with xanthan gum. More specifically, galactomannan such as tara gum has a similar structure to the main chain of xanthan gum, so they aggregate and crosslink between the molecular chains, forming a three-dimensional network structure mainly through hydrogen bonds. However, gelation is possible according to the number of crosslinks per unit volume of the three-dimensional network structure. Locust bean gum with few side chains associates with xanthan gum to form a strong network structure and form an elastic gel. On the other hand, in the case of tara gum having many side chains, it is difficult to form a crosslinking point with xanthan gum due to steric hindrance. The present inventors have found that a gel is formed by cutting low molecular weight components to form high molecular weight tara gum and combining with xanthan gum. That is, in order to improve the gel-forming ability by the combination of xanthan gum and tara gum, it is useful to use a high molecular weight tara gum, and in particular, it is useful to use a tara gum having a high molecular weight and a low molecular weight dispersion. . Here, when high molecular weight tara gum is used, the cross-linked region of the gel formed with xanthan gum increases, and when tara gum having a low molecular weight dispersion is used, the homogeneity of the three-dimensional network structure of the gel increases. . In the present invention, when tara gum having a high molecular weight and a low molecular weight dispersity is used, the cross-linked region of the formed gel can be increased, and the homogeneity of the three-dimensional network structure of the gel can be increased.
市販のタラガムの平均分子量は約25万であるが、本発明では、ゲル浸透クロマトグラフィーで測定した数平均分子量(Mn)30万以上(例えば、35万〜200万)、好ましくは40万以上(例えば、45万〜150万)、さらに好ましくは45万以上(例えば、50万〜120万)、特に60万〜100万のタラガムを用いるのが有利である。 Although the average molecular weight of commercially available tara gum is about 250,000, in the present invention, the number average molecular weight (Mn) measured by gel permeation chromatography is 300,000 or more (for example, 350,000 to 2,000,000), preferably 400,000 or more ( For example, it is advantageous to use 450,000 to 1,500,000, more preferably 450,000 or more (for example, 500,000 to 1,200,000), particularly 600,000 to 1,000,000 of tara gum.
また、キサンタンガムとタラガムとの組み合わせによるゲル形成能及びゲルの均質性を向上させるために、タラガムは、分子量の分散度が小さいことが好ましい。分子量の分散度の指標として、分子量に関して数平均分子量(Mn)と重量平均分子量(Mw)の比(Mw/Mn)が知られている。一般的に、Mw/Mn≧1であり、この比の値が大きいほど、分子量分布が広いことを意味する。市販のタラガムは、Mw/Mnの値は100以上に達するため、市販のタラガムとキサンタンガムとの組み合わせによるゲル形成能は非常に低く、また形成されるゲルの均質性は不十分であると言える。一方、低分子量成分を分別する操作を複数回繰り返すと、Mw/Mn=1.2程度となることが知られている。本発明で用いるタラガムは、ゲル浸透クロマトグラフィーで測定したMw/Mn=10以下(例えば、1〜9)、好ましくは8以下(例えば、1.1〜7)、さらに好ましくは7以下(例えば、1.2〜6.5)、特に6以下(例えば、1.5〜6)である。また、本発明で用いるタラガムは、例えば、数平均分子量(Mn)30万以上で、かつ数平均分子量(Mn)と重量平均分子量(Mw)の比(Mw/Mn)10以下、好ましくはMn40万以上、かつMw/Mn8以下、さらに好ましくはMn50万以上、かつMw/Mn6以下であってもよい。本発明では、前記の高分子量でかつ分子量の分散度の小さいタラガムを用いるため、均質な三次元網目構造を有するゲルを形成することができる。 Moreover, in order to improve the gel formation ability and the gel homogeneity by the combination of xanthan gum and tara gum, it is preferable that the tara gum has a low molecular weight dispersion. As an index of the degree of dispersion of molecular weight, the ratio (Mw / Mn) of the number average molecular weight (Mn) and the weight average molecular weight (Mw) with respect to the molecular weight is known. Generally, Mw / Mn ≧ 1, and the larger the ratio value, the wider the molecular weight distribution. Since the commercially available tara gum has a value of Mw / Mn of 100 or more, it can be said that the gel forming ability by the combination of the commercially available tara gum and xanthan gum is very low, and the homogeneity of the gel formed is insufficient. On the other hand, it is known that when the operation of separating the low molecular weight component is repeated a plurality of times, Mw / Mn = 1.2. The tara gum used in the present invention has Mw / Mn measured by gel permeation chromatography = 10 or less (for example, 1 to 9), preferably 8 or less (for example, 1.1 to 7), more preferably 7 or less (for example, 1.2 to 6.5), particularly 6 or less (for example, 1.5 to 6). The tara gum used in the present invention has, for example, a number average molecular weight (Mn) of 300,000 or more and a ratio of the number average molecular weight (Mn) to the weight average molecular weight (Mw) (Mw / Mn) of 10 or less, preferably Mn 400,000 It may be Mw / Mn 8 or less, more preferably Mn 500,000 or more and Mw / Mn 6 or less. In the present invention, since the tara gum having a high molecular weight and a low molecular weight dispersity is used, a gel having a homogeneous three-dimensional network structure can be formed.
前記タラガムの分画方法又は精製方法は、慣用の方法であってもよい。例えば、前記タラガムは、タラ(Cesalpinia spinosa)の種子から粉砕機又は化学処理により殻を除去した後、分離した胚乳を粉砕し、分画、精製してもよい。胚乳は非常に硬く粉砕しにくいため、市販のタラガムでは、胚乳の粉砕時に、胚乳を高温度下で粉砕又は酵素処理する場合が多い。しかし、高温度下で粉砕又は酵素処理などの過酷な処理を行うと、得られるタラガムの分子量の分散度が大きくなる傾向がある。そのため、本発明では、例えば、高温度下で粉砕せず、穏やかな条件下で粉砕することにより、高分子量でかつ分子量の分散度が小さいタラガムを分画、精製することができる。 The method for fractionating or purifying tara gum may be a conventional method. For example, the tara gum may be obtained by removing shells from seeds of cod (Cesalpinia spinosa) by a pulverizer or chemical treatment, and then pulverizing, fractionating and purifying the separated endosperm. Since endosperm is very hard and difficult to grind, commercially available tara gum is often crushed or enzymatically treated at high temperature during endosperm grinding. However, when a severe treatment such as pulverization or enzyme treatment is performed at a high temperature, the degree of dispersion of the molecular weight of the resulting tara gum tends to increase. Therefore, in the present invention, tara gum having a high molecular weight and a low molecular weight dispersibility can be fractionated and purified by, for example, pulverizing under mild conditions without pulverizing at a high temperature.
キサンタンガムとタラガムとの割合(重量比)は、形成されるゲルが、ゲルの形態を保持しつつ、応力の作用により大変形可能である限り、特に限定されず、通常、キサンタンガム/タラガム(重量比)=10/90〜90/10の範囲から選択することができ、好ましくは20/80〜85/15、さらに好ましくは25/75〜80/20であってもよく、特に25/75〜60/40(例えば、30/70〜50/50)程度であってもよい。例えば、キサンタンガム/タラガム(重量比)=30/70〜80/20であってもよい。 The ratio (weight ratio) of xanthan gum and tara gum is not particularly limited as long as the formed gel can be largely deformed by the action of stress while maintaining the form of the gel. Usually, xanthan gum / tara gum (weight ratio) ) = 10/90 to 90/10, preferably 20/80 to 85/15, more preferably 25/75 to 80/20, especially 25/75 to 60 / 40 (for example, 30/70 to 50/50) may be sufficient. For example, xanthan gum / tara gum (weight ratio) = 30 / 70-80 / 20 may be sufficient.
また、本発明のゲル形成性組成物は、本発明の特性を損なわない範囲で、前記増粘多糖類に加え、さらに他の多糖類を含んでいてもよい。他の多糖類は、特に制限されず、例えば、植物由来多糖類(例えば、ローカストビーンガム、グアーガム、タマリンド種子ガム、ペクチン、アラビアガム、トラガントガム、カラヤガム、ガッティガム、ラーチガムなど)、海藻由来多糖類(例えば、カラギーナン、ファーセルラン、寒天、アルギン酸類など)、微生物産生多糖類(例えば、ジェランガム、カードラン、プルランなど)、その他の多糖類(例えば、グルコマンナン、キチン・キトサンなど)などであってもよい。これらの他の多糖類は単独で又は二種以上組み合わせて使用できる。これらの他の多糖類のうち、カラギーナン、グアーガム及び寒天から選択される少なくとも一種であるのが好ましい。他の多糖類は、キサンタンガム及びタラガムの合計100重量部に対して、0〜50重量部、好ましくは1〜30重量部、さらに好ましくは2〜20重量部(例えば、3〜15重量部程度)であってもよい。 The gel-forming composition of the present invention may further contain other polysaccharides in addition to the thickening polysaccharide as long as the properties of the present invention are not impaired. Other polysaccharides are not particularly limited, and include, for example, plant-derived polysaccharides (eg locust bean gum, guar gum, tamarind seed gum, pectin, gum arabic, tragacanth gum, karaya gum, gati gum, larch gum, etc.), seaweed-derived polysaccharide ( For example, carrageenan, fercellan, agar, alginic acid, etc.), microbially produced polysaccharides (eg, gellan gum, curdlan, pullulan, etc.), other polysaccharides (eg, glucomannan, chitin, chitosan, etc.) Also good. These other polysaccharides can be used alone or in combination of two or more. Of these other polysaccharides, at least one selected from carrageenan, guar gum and agar is preferable. The other polysaccharide is 0 to 50 parts by weight, preferably 1 to 30 parts by weight, more preferably 2 to 20 parts by weight (for example, about 3 to 15 parts by weight) based on 100 parts by weight of xanthan gum and tara gum. It may be.
本発明のゲル形成性組成物は、必要に応じて、保水剤を含んでいてもよい。保水剤としては、例えば、澱粉類(コーンスターチ、馬鈴薯澱粉、甘藷澱粉、小麦澱粉、米澱粉、化工澱粉などの水可溶性澱粉、デキストリン、シクロデキストリンなど)、結晶セルロース類(結晶セルロースなど)、単糖又はオリゴ糖類(乳糖、ブドウ糖、砂糖、還元麦芽糖、水飴、フラクトオリゴ糖、ガラクトオリゴ糖、大豆オリゴ糖、イソマルトオリゴ糖、キシロオリゴ糖、マルトオリゴ糖、乳果オリゴ糖など)、糖アルコール類(ソルビトール、エリスリトール、キシリトール、ラクチトールなど)、アルドン酸、ウロン酸(例えば、D−グルクロン酸、D−ガラクツロン酸など)、糖酸、環状イノシット類(例えば、D−イノシットなど)、デオキシ糖(例えば、L−フコースなど)、アンヒドロ糖、アミノ糖(例えば、D−グルコサミン、D−ガラクトサミンなど)又は酸性ムコ多糖(例えば、ヒアルロン酸、コンドロイチン硫酸又はこれらの塩など)などの糖類が用いられることが多く、多価アルコール(例えば、グリセリン、エチレングリコールなど)、アミノ酸(例えば、プロリン、ヒドロキシプロリン又はこれらの塩など)などを用いてもよい。これらの保水剤のうち、保水力、粘凋性が優れる上に、低価格で、消化・吸収が速やかに行われることなどから、デキストリン(シクロデキストリンを含む)などの澱粉類などが汎用される。これらの保水剤は、本発明で得られる特性に悪影響を与えない範囲で、単独で又は二種以上組み合わせて使用してもよい。 The gel-forming composition of the present invention may contain a water retention agent as necessary. Examples of water-retaining agents include starches (corn starch, potato starch, sweet potato starch, water starch such as wheat starch, rice starch, and modified starch, dextrin, cyclodextrin, etc.), crystalline cellulose (crystalline cellulose, etc.), monosaccharide Or oligosaccharides (lactose, glucose, sugar, reduced maltose, starch syrup, fructooligosaccharide, galactooligosaccharide, soybean oligosaccharide, isomaltooligosaccharide, xylooligosaccharide, maltooligosaccharide, dairy oligosaccharide, etc.), sugar alcohols (sorbitol, erythritol, Xylitol, lactitol, etc.), aldonic acid, uronic acid (eg, D-glucuronic acid, D-galacturonic acid, etc.), sugar acid, cyclic inosites (eg, D-inosit), deoxy sugar (eg, L-fucose, etc.) ), Anhydro sugar, amino sugar (e.g. D-glu) Saccharides such as samine, D-galactosamine) or acidic mucopolysaccharides (for example, hyaluronic acid, chondroitin sulfate or salts thereof) are often used, and polyhydric alcohols (for example, glycerin, ethylene glycol, etc.), amino acids ( For example, proline, hydroxyproline, or a salt thereof may be used. Of these water retention agents, starches such as dextrin (including cyclodextrin) are widely used because of their excellent water retention and viscosity, and low cost and rapid digestion and absorption. . These water retention agents may be used alone or in combination of two or more, as long as the properties obtained in the present invention are not adversely affected.
デキストリンは、特に制限されず、慣用の方法で製造されたものでよく、デンプンを酵素処理(例えば、アミラーゼ消化)又は化学処理(例えば、熱や弱酸による加水分解処理)して得られたものであってもよい。例えば、シクロデキストリン、可溶性デンプン、薄手ノリデンプン、アミロデキストリン、白色デキストリン、黄色デキストリン、ブリティッシュガム、エリトロデキストリン、アクロデキストリン、マルトデキストリンなどが使用できるが、特に、シクロデキストリン、マルトデキストリンが好ましい。 The dextrin is not particularly limited and may be produced by a conventional method, and is obtained by subjecting starch to an enzyme treatment (for example, amylase digestion) or a chemical treatment (for example, hydrolysis treatment with heat or weak acid). There may be. For example, cyclodextrin, soluble starch, thin paste, amylodextrin, white dextrin, yellow dextrin, British gum, erythrodextrin, acrodextrin, maltodextrin and the like can be used, and cyclodextrin and maltodextrin are particularly preferable.
保水剤は、固形分換算で、増粘多糖類1重量部に対して0.1〜30重量部(例えば、1〜25重量部)、好ましくは、0.5〜25重量部(例えば、1〜20重量部)、さらに好ましくは1.5〜20重量部(例えば、3〜15重量部)、通常、2〜13重量部程度である。 A water retention agent is 0.1-30 weight part (for example, 1-25 weight part) with respect to 1 weight part of thickening polysaccharide in solid conversion, Preferably, 0.5-25 weight part (for example, 1). -20 parts by weight), more preferably 1.5-20 parts by weight (for example, 3-15 parts by weight), usually about 2-13 parts by weight.
[ゲル及び嚥下食]
本発明のゲルは、少なくとも前記ゲル形成性組成物及び水性溶媒とで構成される。水性溶媒は、水単独であってもよく、適宜、少量の低級アルコール(例えば、エチルアルコール、グリセリンなど)を含んでいてもよいが、通常、水である。
[Gel and swallowing meal]
The gel of the present invention comprises at least the gel-forming composition and an aqueous solvent. The aqueous solvent may be water alone, and may contain a small amount of a lower alcohol (for example, ethyl alcohol, glycerin, etc.), but is usually water.
本発明では、ゲル形成性組成物及び水性溶媒の全体に対する増粘多糖類の割合を、他の構成成分やその割合に応じ、ゲルの形態を保持しつつ、小さな応力で大変形するゲルを形成可能な範囲で選択できる。本発明では、特定のタラガムを用いて、キサンタンガムとタラガムとの組み合わせによるゲル形成能を向上させているため、前記増粘多糖類の割合が少なくても均質な三次元網目構造を有するゲルが形成される。 In the present invention, the ratio of the thickening polysaccharide to the whole of the gel-forming composition and the aqueous solvent forms a gel that deforms greatly with a small stress while maintaining the form of the gel according to the other components and the ratio. Select as much as possible. In the present invention, a specific tara gum is used to improve the gel forming ability by the combination of xanthan gum and tara gum, so that a gel having a homogeneous three-dimensional network structure is formed even if the proportion of the thickening polysaccharide is small. Is done.
増粘多糖類に対するキサンタンガムの割合が大きくなるにつれ、キサンタンガムとタラガムの単位体積あたりの架橋点の数(架橋密度)が減少し、キサンタンガムとタラガムとの組み合わせによるゲル形成能が低下するようである。そのため、増粘多糖類に対するキサンタンガムの割合が大きくなるにつれ、前記増粘多糖類の割合(重量基準)を大きくするのが好ましい。例えば、ゲルの形態を保持しつつ、小さな応力で大変形するゲルを形成可能である場合の前記増粘多糖類の最小濃度(重量基準)を100とすると、増粘多糖類に対するキサンタンガムの割合が大きくなるにつれ、増粘多糖類の濃度(重量基準)を、100〜650、好ましくは100〜550、さらに好ましくは100〜400、特に100〜350(例えば、100〜250)の範囲で大きくしてもよい。 As the ratio of xanthan gum to thickening polysaccharide increases, the number of cross-linking points (crosslink density) per unit volume of xanthan gum and tara gum decreases, and the gel-forming ability due to the combination of xanthan gum and tara gum appears to decrease. Therefore, it is preferable to increase the ratio (weight basis) of the thickening polysaccharide as the ratio of xanthan gum to the thickening polysaccharide increases. For example, assuming that the minimum concentration (weight basis) of the thickening polysaccharide in the case where it is possible to form a gel that largely deforms with a small stress while maintaining the form of the gel, the ratio of xanthan gum to the thickening polysaccharide is 100. As it increases, the concentration (weight basis) of the thickening polysaccharide is increased in the range of 100 to 650, preferably 100 to 550, more preferably 100 to 400, particularly 100 to 350 (for example, 100 to 250). Also good.
具体的には、前記増粘多糖類の割合は、ゲル形成性組成物及び水性溶媒の全体100重量部に対して0.1〜1重量部(即ち、0.1〜1重量%を意味する)、好ましくは0.15〜0.9重量部、さらに好ましくは0.2〜0.7重量部、特に0.3〜0.7重量部(例えば、0.3〜0.6重量部)程度であってもよい。例えば、キサンタンガムとタラガムとの割合(重量比)が30/70〜50/50の範囲では、前記増粘多糖類の割合は、ゲル形成性組成物及び水性溶媒の全体100重量部に対して0.3〜0.6重量部程度であってもよく、また、キサンタンガムとタラガムとの割合(重量比)が60/40〜80/20の範囲では、前記増粘多糖類の割合は、ゲル形成性組成物及び水性溶媒の全体100重量部に対して0.4〜0.7重量部程度であってもよい。 Specifically, the proportion of the thickening polysaccharide is 0.1 to 1 part by weight (that is, 0.1 to 1% by weight) with respect to 100 parts by weight of the gel-forming composition and the aqueous solvent as a whole. ), Preferably 0.15 to 0.9 parts by weight, more preferably 0.2 to 0.7 parts by weight, especially 0.3 to 0.7 parts by weight (for example, 0.3 to 0.6 parts by weight). It may be a degree. For example, when the ratio (weight ratio) of xanthan gum and tara gum is in the range of 30/70 to 50/50, the ratio of the thickening polysaccharide is 0 with respect to the total of 100 parts by weight of the gel-forming composition and the aqueous solvent. It may be about 3 to 0.6 parts by weight, and when the ratio (weight ratio) of xanthan gum and tara gum is in the range of 60/40 to 80/20, the ratio of the thickening polysaccharide is gel formation. About 0.4-0.7 weight part may be sufficient with respect to 100 weight part of the whole composition and an aqueous solvent.
前記ゲルは、ゲル形成性組成物を、ゲル形成性組成物及び水性溶媒の全体100重量部に対して0.5〜5重量部(即ち、0.5〜5重量%を意味する)、好ましくは1〜4重量部、さらに好ましくは1.5〜3重量部の割合で含んでいてもよい。 The gel is preferably 0.5 to 5 parts by weight (that means 0.5 to 5% by weight) of the gel-forming composition with respect to 100 parts by weight of the gel-forming composition and the aqueous solvent as a whole, preferably May be contained in an amount of 1 to 4 parts by weight, more preferably 1.5 to 3 parts by weight.
また、本発明のゲル形成性組成物又はゲルは、食品、医薬品などの活性成分、例えば、生理活性成分、薬理活性成分を含有していてもよい。 Moreover, the gel-forming composition or gel of the present invention may contain active ingredients such as foods and pharmaceuticals, for example, physiologically active ingredients and pharmacologically active ingredients.
活性成分は、本発明の使用には特に制限されないが、通常、粉末状又は液体状の生理活性成分であり、特に粉末状の生理活性成分が好ましい。また、これらの活性成分は、予め水性溶媒に溶解又は懸濁されていてもよい。 The active ingredient is not particularly limited for use in the present invention, but is usually a powdery or liquid physiologically active ingredient, and a powdery physiologically active ingredient is particularly preferred. Moreover, these active ingredients may be previously dissolved or suspended in an aqueous solvent.
具体的には、生理活性成分としては、例えば、植物体(米、米胚芽、玄米、麦、麦胚芽、粟などの穀類、大豆、小豆、胡麻、南京豆、黒豆、枝豆、空豆などの豆類など)、野菜類(トマト、玉葱、ジャガイモ、サツマイモ、人参、トウモロコシ、ニンニク、ほうれん草、カボチャ、大根など)、各種果汁又は果肉類(ミカン、リンゴ、イチゴ、オレンジ、メロンなど)、獣鳥類(牛肉、豚肉、鶏肉、鶏卵など)、魚介類(サンマ、カツオ、サバ、アジ、イワシなどの魚肉、タラコ、イクラなどの魚卵、ハマグリ、ホタテ、アサリなどの貝類、昆布、ワカメ、ヒジキなどの海藻など)、種実類(クルミ、ピーナッツなど)、粘質類(サトイモ、とろろなど)、乳製品(粉ミルク、粉チーズ、豆乳、ヨーグルトなど)、調味料(食塩、砂糖、味噌、醤油など)などの粉末成分又はその成分エキス、糖質(ショ糖、果糖、ブドウ糖、乳糖、麦芽糖、水飴、還元麦芽糖、キシリトール、ソルビトールなど)、各種油脂類(動物油脂、植物油脂など)、ビタミン類(ビタミンA、ビタミンD、ビタミンEなどの脂溶性ビタミン、又はビタミンB1、ビタミンB2、ビオチン、葉酸、ビタミンC、リポ酸などの水溶性ビタミンなど)、ミネラル類(カルシウム、リン、鉄、ナトリウム、カリウム、マンガンなどを含む塩類)、食物繊維(セルロース、ヘミセルロース、グアーガムなど)、醸造飲料(清酒、洋酒、梅酒、果実酒など)、嗜好飲料粉末(緑茶粉末、コーヒー粉末、ココア粉末など)、ポリフェノール類(茶カテキンや大豆イソフラボンなど)、セラミド類(小麦、米、大豆セラミドなど)、酵素(リパーゼ、コラゲナーゼ、ゼラチナーゼ、アミラーゼ、リゾチームなど)、微生物(ビール酵母などの酵母又は酵母抽出物、乳酸菌など)、アミノ酸(グリシン、L−リジン、L−バリン、L−アラニン、L−アルギニン、L−シスチン、L−メチオニン、L−グルタミン酸、L−アスパラギン酸、タウリン又はこれらの金属塩など)、タンパク質又はペプチド類(L−アルギニン、L−グルタミン酸、L−リジングルタメート、豚、牛、鶏など由来のコラーゲン及びそのコラーゲンペプチドなどのペプチド類、コエンザイムQ10、L−カルニチン又は有機酸塩、シルクプロテイン、シルクペプチドなど)、酸成分(酢酸、黒酢、リンゴ酢などの酢、L−アスコルビン酸、クエン酸、リンゴ酸、酒石酸、シュウ酸、フマル酸、γ−アミノ酪酸などの有機酸又はこれらの金属塩など)、グルコサミン類(キチン、キトサンなど)、ホルモン類などの成分が例示できる。 Specifically, as the physiologically active ingredient, for example, plant bodies (rice, rice germ, brown rice, wheat, wheat germ, cereals such as straw, beans such as soybeans, red beans, sesame seeds, Nanjing beans, black beans, green soybeans, and empty beans) ), Vegetables (tomatoes, onions, potatoes, sweet potatoes, carrots, corn, garlic, spinach, pumpkins, radishes, etc.), various juices or pulps (citrus, apples, strawberries, oranges, melons, etc.), animal birds (beef, Pork, chicken, chicken eggs, etc., seafood (fish such as saury, bonito, mackerel, horse mackerel, sardines), fish eggs such as clams, salmon roe, shellfish such as clams, scallops, clams, seaweeds such as kelp, seaweed, hijiki, etc. ), Seeds (walnuts, peanuts, etc.), stickies (taros, taro, etc.), dairy products (powdered milk, powdered cheese, soy milk, yogurt, etc.), seasonings (salt, sugar, miso) Powdered components such as soy sauce or component extracts thereof, sugars (sucrose, fructose, glucose, lactose, maltose, starch syrup, reduced maltose, xylitol, sorbitol, etc.), various fats (animal fats, vegetable fats, etc.), vitamins (Soluble fats such as vitamin A, vitamin D, vitamin E, or water-soluble vitamins such as vitamin B 1 , vitamin B 2 , biotin, folic acid, vitamin C, lipoic acid), minerals (calcium, phosphorus, iron, etc.) , Salt containing sodium, potassium, manganese, etc.), dietary fiber (cellulose, hemicellulose, guar gum, etc.), brewed beverage (sake, western liquor, plum wine, fruit liquor, etc.), taste beverage powder (green tea powder, coffee powder, cocoa powder, etc.) ), Polyphenols (such as tea catechins and soy isoflavones), ceramides (wheat, rice, soy ceramics) Etc.), enzymes (lipase, collagenase, gelatinase, amylase, lysozyme, etc.), microorganisms (yeast such as beer yeast or yeast extract, lactic acid bacteria, etc.), amino acids (glycine, L-lysine, L-valine, L-alanine, L -Arginine, L-cystine, L-methionine, L-glutamic acid, L-aspartic acid, taurine or a metal salt thereof, protein or peptides (L-arginine, L-glutamic acid, L-lysine glutamate, pig, cow , Collagen derived from chicken and the like and peptides such as collagen peptides thereof, coenzyme Q 10 , L-carnitine or organic acid salt, silk protein, silk peptide, etc.), acid component (vinegar such as acetic acid, black vinegar, apple vinegar, L -Ascorbic acid, citric acid, malic acid, tartaric acid, oxalic acid, fumar Examples include components such as acids, organic acids such as γ-aminobutyric acid or metal salts thereof, glucosamines (such as chitin and chitosan), and hormones.
薬理活性成分としては、例えば、抗アレルギー薬(クロモグリク酸ナトリウムなど)、抗ヒスタミン薬(ジフェンヒドラミン、ピリラミンなど)、抗炎症薬(イブプロフェン、インドメタシンなど)、睡眠薬(ニトラゼパム、バルビタールなど)、抗精神病薬、鎮痛薬、抗高血圧薬、健胃薬、消化薬、抗菌薬又は抗生物質などの成分、又は生薬成分(カッコン、アロエ、アマチャヅル、ウコンなど)などが挙げられる。 Examples of pharmacologically active ingredients include antiallergic drugs (such as cromoglycate sodium), antihistamines (such as diphenhydramine and pyrilamine), anti-inflammatory drugs (such as ibuprofen and indomethacin), sleeping drugs (such as nitrazepam and barbital), antipsychotic drugs, Ingredients such as analgesics, antihypertensives, stomachicides, digestives, antibacterials or antibiotics, or herbal medicines (such as cuckoo, aloe, hamchael, turmeric) are included.
上記活性成分と併せて、各種添加剤を含んでいてもよい。添加剤としては、例えば、甘味料(前記糖質類、サッカリンナトリウム、カンゾウエキスなど)、香辛料(ブラックペパー、バジル、シナモンなど)、着色料、保存料、糊料、酸化防止剤、発色剤、漂白剤、乳化剤、pH調整剤、結合剤、懸濁化剤、光沢化剤、湿潤剤、消泡剤、清涼化剤、等張化剤、粘着剤、粘凋剤、離型剤、香料又は天然物の加水分解物類(グルタミン酸ナトリウム、イノシン酸ナトリウムなど)などの成分が例示できる。 Various additives may be contained in combination with the active ingredient. Examples of additives include sweeteners (the aforementioned carbohydrates, saccharin sodium, licorice extract, etc.), spices (black pepper, basil, cinnamon, etc.), coloring agents, preservatives, pastes, antioxidants, color formers, bleaching agents. Agent, emulsifier, pH adjuster, binder, suspending agent, brightening agent, wetting agent, antifoaming agent, refreshing agent, tonicity agent, adhesive, viscous agent, mold release agent, perfume or natural Ingredients such as product hydrolysates (sodium glutamate, sodium inosinate, etc.) can be exemplified.
これらの活性成分のうち、通常、穀類、豆類、野菜類、果汁又は果肉類、食肉、鶏卵、魚介類、調味料、糖質、ビタミン類、ミネラル類、嗜好飲料粉末などの成分が用いられる。これらの成分は単独で又は二種以上組み合わせて使用できる。 Of these active ingredients, ingredients such as cereals, beans, vegetables, fruit juices or flesh, meat, chicken eggs, seafood, seasonings, saccharides, vitamins, minerals, and liquor powder are usually used. These components can be used alone or in combination of two or more.
活性成分は、後述の通り、熱で変性又は分解し得る成分であってもよく、例えば、タンパク質、ペプチド及びビタミンから選択される少なくとも一種の成分であってもよい。活性成分は、特に制限されないが、高分子量でかつ高粘度の活性成分を用いると、ゲル形成を損なう場合があるため、分子量(又は数平均分子量Mn)15000以下(例えば、100〜8000)、好ましくは10000以下(例えば、150〜7000)、さらに好ましくは、200〜5000程度でかつ粘性が高くない成分を用いることが好ましい。 As described later, the active ingredient may be a component that can be denatured or decomposed by heat, and may be, for example, at least one component selected from proteins, peptides, and vitamins. The active ingredient is not particularly limited, but if a high molecular weight and high viscosity active ingredient is used, gel formation may be impaired. Therefore, the molecular weight (or number average molecular weight Mn) is 15000 or less (for example, 100 to 8000), preferably Is 10000 or less (for example, 150 to 7000), more preferably about 200 to 5000 and a component having a low viscosity is preferably used.
本発明のゲル形成性組成物又はゲルに活性成分を含有させる場合、ゲルの三次元網目構造の架橋点は、添加する活性成分によって形成阻害又は破壊される傾向があるため、前記活性成分の割合を、目的のゲル特性に応じて調整することが好ましい。 When an active ingredient is contained in the gel-forming composition or gel of the present invention, the crosslinking point of the three-dimensional network structure of the gel tends to be inhibited or destroyed by the active ingredient to be added. Is preferably adjusted according to the desired gel properties.
例えば、活性成分の割合は、活性成分が生理活性成分の場合、固形分換算で、ゲル形成性組成物中の増粘多糖類1重量部に対して1〜50重量部、好ましくは5〜40重量部、さらに好ましくは10〜35重量部(例えば、15〜30重量部)程度であってもよい。また、活性成分の割合は、活性成分が生理活性成分である場合、ゲル形成性組成物及び水性溶媒の全体100重量部に対しては1〜20重量部、好ましくは2〜15重量部、さらに好ましくは2.5〜15重量部(例えば、5〜10重量部)程度であってもよい。活性成分が薬理活性成分の場合、固形分換算で、ゲル形成性組成物中の増粘多糖類1重量部に対して0.001〜0.5重量部、好ましくは0.005〜0.1重量部、さらに好ましくは0.01〜0.05重量部程度であってもよい。また、活性成分の割合は、活性成分が薬理活性成分である場合、ゲル形成性組成物及び水性溶媒の全体100重量部に対して0.001〜0.1重量部、好ましくは0.002〜0.05重量部、さらに好ましくは0.003〜0.01重量部であってもよい。前記の通り、本発明では、増粘多糖類の割合が小さくても、活性成分を比較的多く添加できるため、嚥下食の摂取量が少量であっても、十分な栄養補給が可能となる。 For example, when the active ingredient is a physiologically active ingredient, the ratio of the active ingredient is 1 to 50 parts by weight, preferably 5 to 40 parts per 1 part by weight of the thickening polysaccharide in the gel-forming composition in terms of solid content. It may be about 10 parts by weight, more preferably about 10 to 35 parts by weight (for example, 15 to 30 parts by weight). In addition, when the active ingredient is a physiologically active ingredient, the ratio of the active ingredient is 1 to 20 parts by weight, preferably 2 to 15 parts by weight with respect to 100 parts by weight of the total gel-forming composition and aqueous solvent. Preferably, it may be about 2.5 to 15 parts by weight (for example, 5 to 10 parts by weight). When the active ingredient is a pharmacologically active ingredient, in terms of solid content, 0.001 to 0.5 parts by weight, preferably 0.005 to 0.1 parts per 1 part by weight of the thickening polysaccharide in the gel-forming composition. Part by weight, more preferably about 0.01 to 0.05 part by weight may be used. In addition, when the active ingredient is a pharmacologically active ingredient, the proportion of the active ingredient is 0.001 to 0.1 parts by weight, preferably 0.002 to 100 parts by weight of the entire gel-forming composition and aqueous solvent. It may be 0.05 parts by weight, more preferably 0.003 to 0.01 parts by weight. As described above, in the present invention, even if the proportion of thickening polysaccharide is small, a relatively large amount of active ingredient can be added, so that sufficient nutritional supplementation is possible even if the amount of swallowed food intake is small.
なお、活性成分を含有したゲルは、前記増粘多糖類を0.05〜0.9重量%、好ましくは0.1〜0.85重量%、さらに好ましくは0.15〜0.8重量%、特に0.2〜0.7重量%(例えば、0.25〜0.6重量%)の割合で有していてもよい。また、活性成分を含有したゲルは、ゲル形成性組成物を0.05〜4重量%、好ましくは0.5〜3.5重量%、さらに好ましくは1〜2.5重量%の割合で有していてもよい。 The gel containing the active ingredient is 0.05 to 0.9 wt%, preferably 0.1 to 0.85 wt%, more preferably 0.15 to 0.8 wt% of the thickening polysaccharide. In particular, it may have a ratio of 0.2 to 0.7% by weight (for example, 0.25 to 0.6% by weight). The gel containing the active ingredient contains the gel-forming composition in a proportion of 0.05 to 4% by weight, preferably 0.5 to 3.5% by weight, more preferably 1 to 2.5% by weight. You may do it.
本発明のゲルは、ゲルの三次元網目構造が十分に進行していないため、形を保持しつつ流動し、小さな応力に対して大きく変形する性質を有する。この性質は一般的なゲルとは異なる特性であるため、本発明のゲルを一般的なゲルと区別して、「流れるゼリー」又は「フローゼリー」と称する場合がある。このフローゼリー状態にあるゲルは嚥下食に好適である。 The gel of the present invention has the property that the three-dimensional network structure of the gel is not sufficiently advanced, so that the gel flows while maintaining its shape and is greatly deformed with respect to a small stress. Since this property is a characteristic different from that of a general gel, the gel of the present invention may be referred to as “flowing jelly” or “flow jelly” in distinction from a general gel. This gel in the flow jelly state is suitable for swallowing food.
本発明のフローゼリー状態のゲル及び嚥下食は小さな応力で大変形する。このような特性は、前記変形率に対する力学的正接損失(tanδ)の変曲点における変形率及び前記変曲点における力学的正接損失(tanδ)とで評価でき、本発明のゲルは、前記変曲点における変形率が20〜50%、好ましくは25〜45%、さらに好ましくは30〜40%、特に33〜36%(例えば、34%)程度である。また、前記変曲点における力学的正接損失(tanδ)が0.1〜1、好ましくは0.1〜0.95、さらに好ましくは0.15〜0.9、特に、0.15〜0.8である。変形率、貯蔵弾性率(G’)及び力学的正接損失(tanδ)などの特性は、ゲル特性及び嚥下のし易さの指標となる。 The gel and swallow food in the flow jelly state of the present invention undergoes large deformation with small stress. Such characteristics can be evaluated by the deformation rate at the inflection point of the mechanical tangent loss (tan δ) with respect to the deformation rate and the mechanical tangent loss (tan δ) at the inflection point. The deformation rate at the inflection point is 20 to 50%, preferably 25 to 45%, more preferably 30 to 40%, particularly 33 to 36% (for example, 34%). The mechanical tangent loss (tan δ) at the inflection point is 0.1 to 1, preferably 0.1 to 0.95, more preferably 0.15 to 0.9, particularly 0.15 to 0.3. 8. Properties such as deformation rate, storage modulus (G ') and mechanical tangent loss (tan δ) are indicative of gel properties and ease of swallowing.
力学的正接損失(tanδ)は、貯蔵弾性率(G’)に対する損失弾性率(G”)の比(G”/G’)である。ここで、貯蔵弾性率(G’)は、ゲルにひずみを与えても壊れない強い結合の数、すなわち、単位体積あたりの強い結合の数に比例し、ゲルの硬さを表す弾性成分である。損失弾性率(G”)は、ゲルにひずみを与えると壊れて、熱エネルギーとなる弱い結合の数、すなわち、単位体積あたりの弱い結合の数に比例し、ゲルの軟らかさを表す粘性成分である。さらに、粘弾性を有するゲルに応力を加えると、徐々に変形が起こる。応力が小さい間は、応力とひずみの間で線形性が成り立つが、応力が大きくなると、線形性が保持できなくなり、ゲル構造が急激に変化する点が出現する。変形率に対する力学的正接損失(tanδ)の変曲点は、変形率と前記力学的正接損失tanδとの関係において、変形率の変化に伴い、一定の比例関係で変化していたtanδが、急激にその比例関係を変化させる点として示され、ゲル構造の変化点とも表すことができる。上記変形率、貯蔵弾性率(G’)及び力学的正接損失(tanδ)などの特性は、動的粘弾性測定で求めることができる。 The mechanical tangent loss (tan δ) is the ratio (G ″ / G ′) of the loss elastic modulus (G ″) to the storage elastic modulus (G ′). Here, the storage elastic modulus (G ′) is an elastic component that is proportional to the number of strong bonds that do not break even when the gel is strained, that is, the number of strong bonds per unit volume, and represents the hardness of the gel. . The loss elastic modulus (G ″) is a viscous component that is proportional to the number of weak bonds that break when the gel is strained and becomes thermal energy, that is, the number of weak bonds per unit volume, and represents the softness of the gel. In addition, when stress is applied to a gel having viscoelasticity, deformation occurs gradually.When the stress is small, linearity is established between stress and strain, but when the stress is large, linearity cannot be maintained. The inflection point of the mechanical tangent loss (tan δ) with respect to the deformation rate is related to the change of the deformation rate in the relationship between the deformation rate and the mechanical tangent loss tan δ. Tan δ, which has changed in a certain proportional relationship, is shown as a point where the proportional relationship is suddenly changed, and can also be expressed as a change point of the gel structure.The deformation rate, storage elastic modulus (G ′) and mechanical Tangent loss tan [delta) properties such as can be determined by dynamic viscoelasticity measurement.
硬いゲル状態のゲルは、ゲルの三次元網目構造が十分に進行しており、容器を傾けると、ゲルは形態を保持するものの、応力に対してさほど変形せず、前記力学的正接損失(tanδ)の変曲点における変形率はほぼ11%である。このような性質のゲルは、パサつき感、弾力性があり、嚥下食にすると、咽頭から気管に入る誤嚥のおそれがある。 The gel in a hard gel state has a sufficiently advanced three-dimensional network structure of the gel. When the container is tilted, the gel retains its shape but does not deform so much with respect to the stress, and the mechanical tangent loss (tan δ) ) At the inflection point is approximately 11%. The gel having such properties has a feeling of softness and elasticity, and if swallowed, there is a risk of aspiration entering the trachea from the pharynx.
ゾル状態(トロミ状態)の溶液は、容器を傾けると、形態を自在に変化させながら流動する。これらの溶液の変曲点における変形率はほぼ69%である。このような性質の溶液は、付着性が大きく、嚥下食にすると、水分の少ない嚥下障害者の咽頭の粘膜に付着し易くなる。 When the container is tilted, the sol state (tromi state) solution flows while freely changing its form. The deformation rate at the inflection point of these solutions is approximately 69%. A solution having such a property has high adhesion, and when swallowed, it tends to adhere to the mucous membrane of the pharynx of a person with dysphagia having little water.
本発明のゲル及び嚥下食は、硬いゲル状態とトロミ状態との中間の性質を示し、ゲルの形態を保持しつつ大変形性を有するため、咽頭を通過する際にも大変形できる。この性質は、食塊が、複雑な構造をした咽頭内を一瞬で通過し、嚥下がスムーズに行われるために重要である。 The gel and swallowing meal of the present invention exhibit intermediate properties between a hard gel state and a troglodyte state, and have large deformability while maintaining the gel form, so that they can be greatly deformed even when passing through the pharynx. This property is important because the bolus passes through the pharynx having a complicated structure in an instant, and swallowing is performed smoothly.
本発明のゲル及び嚥下食は、前記活性成分を前記割合で含有させてもフローゼリー状態を保持する。さらに、本発明のゲル及び嚥下食は、非加熱条件下又は低温下(例えば、0〜35℃、特に10〜25℃)でも調製できる。そのため、本発明のゲル及び嚥下食は、熱で変性又は分解し得る成分(例えば、タンパク質、ペプチド又はビタミンなど)と組み合わせても、成分の凝集・沈殿が低減され、かつ嚥下に好適なゲル特性(例えば、大変形性、粘性など)を保持する。 The gel and swallowing meal of the present invention maintain the flow jelly state even when the active ingredient is contained in the above ratio. Furthermore, the gel and swallowing meal of the present invention can also be prepared under non-heated conditions or under low temperature (for example, 0 to 35 ° C., particularly 10 to 25 ° C.). Therefore, even if the gel and swallowing meal of the present invention are combined with a component that can be denatured or decomposed by heat (for example, protein, peptide, vitamin, etc.), the aggregation / precipitation of the component is reduced, and the gel characteristics suitable for swallowing (For example, large deformability, viscosity, etc.) are retained.
また、本発明のゲル及び嚥下食において、ゲルの融解温度は、増粘多糖類の割合に影響される。例えば、前記増粘多糖類の割合が、ゲル形成性組成物及び水性溶媒の全体100重量部に対して0.4重量部以上である場合、ゲルは融解温度45℃以上を示すため、夏場でもゲルは融解せず、さらに、嚥下中に咽頭内で融解することなく、日常において安定性に優れ、ゼラチンの欠点を克服することが可能である。さらに、本発明のゲル及び嚥下食は、多数の水酸基や極性基を有する高度な分岐構造のキサンタンガム及びタラガムで構成されているため、ゲル表面が水和された状態である。そのため、本発明のゲル及び嚥下食は、保水力が高く、水分量が減少した咽頭内を滑らかに通過することができる。また、凍結・融解を反復してもほとんど離水しない凍結耐性(耐凍結安定性)をも併せもつ。 In the gel and swallowing meal of the present invention, the melting temperature of the gel is affected by the proportion of the thickening polysaccharide. For example, when the proportion of the thickening polysaccharide is 0.4 parts by weight or more with respect to 100 parts by weight of the total of the gel-forming composition and the aqueous solvent, the gel exhibits a melting temperature of 45 ° C. or more, so even in summer The gel does not melt, and furthermore, without melting in the pharynx during swallowing, it has excellent stability on a daily basis and can overcome the disadvantages of gelatin. Furthermore, since the gel and swallowing meal of the present invention are composed of highly branched xanthan gum and tara gum having a large number of hydroxyl groups and polar groups, the gel surface is in a hydrated state. Therefore, the gel and swallowing meal of the present invention have a high water retention ability and can smoothly pass through the pharynx with a reduced amount of water. It also has freezing resistance (freezing stability) that hardly waters even after repeated freezing and thawing.
一般的にゲルは多量の液体を含むが、自重では流動せずに形を保っている状態であると定義でき、液体と固体との中間状態で「第4の物質」とも称される。例えば、プリンやデザートゼリーなどがゲルに分類されるが、重力が作用してもその形状は通常変化しない。一方、フローゼリー状態のゲルは離水することなく、形を保持したまま自在に流動する。両者から嚥下食を調理・加工した場合、嚥下食の味、香り、舌ざわり、のど越し及び摂取量に差異が生じる。このような差異は、フローゼリーの三次元網目構造に起因しており、嚥下食をフローゼリー状態に調整すると、食品のもつ微妙な味や香りを表現することができる。 In general, a gel contains a large amount of liquid, but it can be defined as a state in which it does not flow under its own weight and maintains its shape, and is also called a “fourth substance” in an intermediate state between a liquid and a solid. For example, pudding and dessert jelly are classified as gels, but their shape usually does not change even when gravity acts. On the other hand, the gel in the flow jelly state flows freely while maintaining its shape without water separation. When the swallowed food is cooked and processed from both, there is a difference in the taste, aroma, texture, throat and intake of the swallowed food. Such a difference is caused by the three-dimensional network structure of the flow jelly, and when the swallowing food is adjusted to the flow jelly state, the delicate taste and aroma of the food can be expressed.
なお、本発明のゲル及び嚥下食は、フローゼリー状態を有しているが、増粘多糖類に対するキサンタンガムの割合を大きく、又はゲル形成性組成物及び水性溶媒の全体に対する増粘多糖類の割合を小さくすると、ゲル中の三次元網目構造の架橋密度が減少し、より流動性の高いゾル状態の方向に移動する。フローゼリー状態の中でも、ゾル状態に近いフローゼリーに調整すると、摂食一回あたりのフローゼリーの摂取量を増やすことができる。即ち、同じフローゼリー状態であっても、ゲルの三次元網目構造の架橋密度に応じて、摂食一回あたりの摂取量を調節できることは、工業生産において非常に興味深く、かつ本発明のゲル及び嚥下食の利用可能性を広げる。 In addition, although the gel and swallowing meal of this invention have a flow jelly state, the ratio of the xanthan gum with respect to a thickening polysaccharide is large, or the ratio of the thickening polysaccharide with respect to the whole gel-forming composition and an aqueous solvent. When the value is reduced, the crosslink density of the three-dimensional network structure in the gel decreases, and the gel moves in the direction of a sol state with higher fluidity. If the flow jelly state is adjusted to a flow jelly that is close to the sol state, the amount of flow jelly consumed per meal can be increased. That is, even in the same flow jelly state, it is very interesting in industrial production that the intake per one meal can be adjusted according to the cross-linking density of the three-dimensional network structure of the gel. Expand the availability of swallowing food.
[製造方法]
本発明のゲル形成性組成物は、少なくともキサンタンガムとタラガムと、必要により保水剤とを、前記割合で混合して製造することができる。また、本発明のゲル形成性組成物は、増粘多糖類に、他の多糖類(例えば、カラギーナン、グアーガム、寒天など)をも前記割合で混合して製造してもよい。各成分は、粉末状の形態や液体状の形態で混合してもよい。
[Production method]
The gel-forming composition of the present invention can be produced by mixing at least xanthan gum and tara gum and, if necessary, a water retention agent at the above ratio. The gel-forming composition of the present invention may be produced by mixing thickening polysaccharides with other polysaccharides (for example, carrageenan, guar gum, agar, etc.) in the above ratio. Each component may be mixed in a powder form or a liquid form.
本発明のゲル形成性組成物を、水性溶媒と前記割合で混合し、溶解して得られたゲル溶液を冷却すると、さらにゲル化が進行する。本発明のゲル形成性組成物は、水性溶媒と、非加熱条件下又は低温下で混合し、攪拌しながら徐々に溶解して得られたゲル溶液を、そのまま放置冷却するとさらにゲル化が進み、ゲルを形成する。なお、ゲル形成に要する時間を短縮し、かつ均質性及び粘性に優れるゲルを得るために、前記ゲル溶液を、融解温度未満の温度(例えば、25〜70℃、好ましくは28〜65℃、さらに好ましくは30〜60℃、特に、35〜55℃程度)で加熱した後、冷却すればよい。本発明では、ゲル形成過程で活性成分を前記割合で含有させ、上記方法でゲルを調製し、得られたゲルを嚥下食としてもよい。 When the gel-forming composition of the present invention is mixed with an aqueous solvent at the above ratio and dissolved, and the gel solution obtained is cooled, gelation further proceeds. The gel-forming composition of the present invention is mixed with an aqueous solvent under non-heating conditions or at a low temperature, and the gel solution obtained by gradually dissolving with stirring is allowed to cool as it is, and further gelation proceeds. Form a gel. In order to shorten the time required for gel formation and obtain a gel having excellent homogeneity and viscosity, the gel solution is heated to a temperature lower than the melting temperature (for example, 25 to 70 ° C, preferably 28 to 65 ° C, Preferably, after heating at 30 to 60 ° C., particularly about 35 to 55 ° C., cooling may be performed. In the present invention, the active ingredient may be contained in the above-described ratio during the gel formation process, the gel may be prepared by the above method, and the obtained gel may be used as a swallowing meal.
本発明のゲル形成性組成物は、小さな応力で大変形可能なゲルを形成できるため、スムーズに、かつ安全に嚥下できることが求められている摂食・嚥下障害者や高齢者などの嚥下食に有用である。とりわけ、本発明のゲル形成性組成物は、熱で変性又は分解し得る成分(例えば、タンパク質、ペプチド又はビタミンなど)を含有する嚥下食に好適であり、たんぱく質・エネルギー低栄養状態(Protein Energy Malnutrition,PEM)やビタミン欠乏症などの特定栄養素欠乏症の予防又は早期治療、さらに、特定栄養素欠乏症に起因する寝たきり状態、摂食・嚥下障害、生活習慣病、認知症又はうつ病などの障害・疾病を予防・改善することができる。また、本発明のゲル及び嚥下食は、安価で、調理・加工がし易い上に、凍結耐性(耐凍結安定性)を有していることから、嚥下食の冷凍保存及び広汎な利用が可能であり、例えば、病院食、高齢者のための施設での食事への利用に適している。さらに、嚥下機能が未発達な乳児用の離乳食又は幼児用の食品への利用にも適している。 Since the gel-forming composition of the present invention can form a gel that can be deformed with a small amount of stress, it can be used for swallowing foods such as eating and dysphagia patients and elderly people who are required to be able to swallow smoothly and safely. Useful. In particular, the gel-forming composition of the present invention is suitable for swallowing foods containing components that can be denatured or decomposed by heat (for example, proteins, peptides, vitamins, etc.), and is protein and energy malnutrition (Protein Energy Malnutrition). , PEM), prevention or early treatment of specific nutrient deficiencies such as vitamin deficiency, and prevention of bedridden conditions, eating / swallowing disorders, lifestyle-related diseases, dementia or depression due to specific nutrient deficiencies・ I can improve. In addition, the gel and swallow food of the present invention are inexpensive, easy to cook and process, and have freezing tolerance (freeze stability), so that swallow food can be stored frozen and widely used. For example, it is suitable for use in hospital foods and meals in facilities for elderly people. Furthermore, it is also suitable for use as baby food for infants or infant foods with an underdeveloped swallowing function.
以下に、実施例に基づいて本発明をより詳細に説明するが、本発明はこれらの実施例によって限定されるものではない。なお、以下の例において貯蔵弾性率G’、損失弾性率G”、力学的正接損失tanδ、変形率に対する力学的正接損失(tanδ)の変曲点における変形率は、以下のようにして測定した。 Hereinafter, the present invention will be described in more detail based on examples, but the present invention is not limited to these examples. In the following examples, the storage elastic modulus G ′, the loss elastic modulus G ″, the mechanical tangent loss tan δ, and the deformation rate at the inflection point of the mechanical tangent loss (tan δ) with respect to the deformation rate were measured as follows. .
得られた嚥下食の動的粘弾性を以下の条件で測定した。 The dynamic viscoelasticity of the obtained swallowing meal was measured under the following conditions.
測定機種:(株)ユービーエム製、商品名「Rheosol−G3000」
測定法:動的粘弾性測定
測定モード:変形率、温度依存性
チャック:パラレルプレート
波形:正弦波
パラレル半径:40mm
厚み:1mm
ギャップ:3mm
条件:25℃1deg
トルクFs:2.04
ロードセル:10.2kg。
Measurement model: Product name “Rheosol-G3000” manufactured by UBM Co., Ltd.
Measurement method: Dynamic viscoelasticity measurement Measurement mode: Deformation rate, temperature dependence Chuck: Parallel plate Waveform: Sine wave Parallel radius: 40mm
Thickness: 1mm
Gap: 3mm
Condition: 25 °
Torque Fs: 2.04
Load cell: 10.2 kg.
実施例1
キサンタンガムとタラガムとを、キサンタンガム/タラガム(重量比)=40/60の割合で組み合わせた増粘多糖類0.4重量部、デキストリン1.6重量部、低ゲル化性ホエイタンパク質2重量部、コラーゲンペプチド4重量部及び砂糖2.5重量部を水89.5重量部に添加し、数分間膨潤させた。得られた水性ゲルを50℃まで徐々に加熱し、50℃で約20分攪拌して溶解した。その後、室温まで放冷し、冷蔵庫で1時間以上放置すると、フローゼリー状態の嚥下食が得られた。得られた嚥下食の力学的正接損失tanδ、変形率を25℃で測定し、両者の関係を図1に示す。
Example 1
0.4 parts by weight of thickening polysaccharide, xanthan gum, 1.6 parts by weight of dextrin, 2 parts by weight of low gelling whey protein, collagen, wherein xanthan gum and tara gum are combined in a ratio of xanthan gum / tara gum (weight ratio) = 40/60 4 parts by weight of peptide and 2.5 parts by weight of sugar were added to 89.5 parts by weight of water and allowed to swell for several minutes. The obtained aqueous gel was gradually heated to 50 ° C. and stirred at 50 ° C. for about 20 minutes to dissolve. Then, when allowed to cool to room temperature and left in the refrigerator for 1 hour or longer, a swallowing meal in a flow jelly state was obtained. The mechanical tangent loss tan δ and deformation rate of the swallowed food obtained were measured at 25 ° C., and the relationship between them is shown in FIG.
ここで、用いた低ゲル化性ホエイタンパク質の成分表示は以下の通りである。なお、下記成分は低ゲル化性ホエイタンパク質100gあたりの成分を表す。 Here, the component display of the used low-gelling whey protein is as follows. In addition, the following component represents a component per 100 g of the low gelling whey protein.
(低ゲル化性ホエイタンパク質)
タンパク質:83.6重量%
脂肪:6.2重量%
水:3.9重量%
乳糖:6.7重量%
灰分:2.8重量%
ナトリウム:248mg
カリウム:580mg
塩素:43mg
カルシウム:361mg
リン:280mg。
(Low gelling whey protein)
Protein: 83.6% by weight
Fat: 6.2% by weight
Water: 3.9% by weight
Lactose: 6.7% by weight
Ash content: 2.8% by weight
Sodium: 248mg
Potassium: 580mg
Chlorine: 43mg
Calcium: 361 mg
Phosphorus: 280 mg.
実施例2
キサンタンガム/タラガム(重量比)=80/20の割合で組み合わせた増粘多糖類を0.4重量部用いる以外は実施例1と同様にして嚥下食を調製した。得られた嚥下食の力学的正接損失tanδ、変形率を25℃で測定し、両者の関係を図1に示す。
Example 2
A swallow meal was prepared in the same manner as in Example 1 except that 0.4 parts by weight of the thickening polysaccharide combined at a ratio of xanthan gum / tara gum (weight ratio) = 80/20 was used. The mechanical tangent loss tan δ and deformation rate of the swallowed food obtained were measured at 25 ° C., and the relationship between them is shown in FIG.
実施例3
キサンタンガム/タラガム(重量比)=30/70の割合で組み合わせた増粘多糖類を0.4重量部用いる以外は実施例1と同様にして嚥下食を調製した。得られた嚥下食の力学的正接損失tanδ、変形率を25℃で測定し、両者の関係を図1に示す。
Example 3
A swallowing meal was prepared in the same manner as in Example 1 except that 0.4 parts by weight of the thickening polysaccharide combined at a ratio of xanthan gum / tara gum (weight ratio) = 30/70 was used. The mechanical tangent loss tan δ and deformation rate of the swallowed food obtained were measured at 25 ° C., and the relationship between them is shown in FIG.
実施例4
キサンタンガム/タラガム(重量比)=40/60の割合で組み合わせた増粘多糖類を0,5重量部用いる以外は実施例1と同様にして嚥下食を調製した。得られた嚥下食の力学的正接損失tanδ、変形率を25℃で測定し、両者の関係を図1に示す。
Example 4
A swallow meal was prepared in the same manner as in Example 1 except that 0.5 parts by weight of the thickening polysaccharide combined at a ratio of xanthan gum / tara gum (weight ratio) = 40/60 was used. The mechanical tangent loss tan δ and deformation rate of the swallowed food obtained were measured at 25 ° C., and the relationship between them is shown in FIG.
実施例5
キサンタンガム/タラガム(重量比)=40/60の割合で組み合わせた増粘多糖類を0.6重量部用いる以外は実施例1と同様にして嚥下食を調製した。得られた嚥下食の力学的正接損失tanδ、変形率を25℃で測定し、両者の関係を図1に示す。
Example 5
A swallowing meal was prepared in the same manner as in Example 1 except that 0.6 parts by weight of the thickening polysaccharide combined at a ratio of xanthan gum / tara gum (weight ratio) = 40/60 was used. The mechanical tangent loss tan δ and deformation rate of the swallowed food obtained were measured at 25 ° C., and the relationship between them is shown in FIG.
実施例6
キサンタンガム/タラガム(重量比)=80/20の割合で組み合わせた増粘多糖類を0.7重量部用いる以外は実施例1と同様にして嚥下食を調製した。得られた嚥下食の力学的正接損失tanδ、変形率を25℃で測定し、両者の関係を図1に示す。
Example 6
A swallowing meal was prepared in the same manner as in Example 1 except that 0.7 parts by weight of the thickening polysaccharide combined at a ratio of xanthan gum / tara gum (weight ratio) = 80/20 was used. The mechanical tangent loss tan δ and deformation rate of the swallowed food obtained were measured at 25 ° C., and the relationship between them is shown in FIG.
なお、図1の矢印は、変形率に対する力学的正接損失(tanδ)の変曲点(ゲル構造の変化点)を示す。変形率と力学的正接損失tanδとの関係は、キサンタンガムとタラガムとの割合(重量比)や、増粘多糖類の割合(重量基準)を変えても、34%付近(図中の矢印)までは、ほぼ線型性が成立するが、その後、変形率の増加とともに力学的正接損失tanδの値は増加する。この挙動は、ひずみを加えたときに壊れ、熱エネルギーになる弱い結合量を示す損失弾性率(G”)と、ひずみを与えても壊れない強い結合量を示す貯蔵弾性率(G’)では、ひずみの増加で受ける影響が、変形率30〜40%(特に、34%程度)で、損失弾性率(G”)>貯蔵弾性率(G’)となることに起因していると推定される。この挙動を示すゲルは、弾力性と付着性のバランスに優れ、流動性を有するフローゼリー状態であるため、小さな応力で大変形する。また、力学的正接損失tanδの値は、食塊が嚥下に好適な状態である範囲(0.1〜1)にある。キサンタンガムとタラガムとの割合(重量比)、増粘多糖類の割合(重量基準)を変えても、tanδの値がほとんど変わらないのは、両ガム分子鎖間の架橋密度が変化するに伴い、貯蔵弾性率G’の値は変化するが、三次元網目構造の架橋点(主として水素結合)の質的性質が変わらないためとみられる。 In addition, the arrow of FIG. 1 shows the inflexion point (change point of a gel structure) of the dynamic tangent loss (tan-delta) with respect to a deformation rate. The relationship between the deformation rate and the mechanical tangent loss tan δ is around 34% (arrow in the figure) even if the ratio of xanthan gum and tara gum (weight ratio) and the ratio of thickening polysaccharide (weight basis) are changed. Is substantially linear, but thereafter, the value of the mechanical tangent loss tan δ increases as the deformation rate increases. This behavior is caused by a loss elastic modulus (G ″) that indicates a weak bond amount that breaks and becomes thermal energy when strain is applied, and a storage elastic modulus (G ′) that indicates a strong bond amount that does not break even when strain is applied. It is estimated that the effect of the increase in strain is due to the deformation rate of 30 to 40% (particularly about 34%) and the loss elastic modulus (G ″)> storage elastic modulus (G ′). The A gel exhibiting this behavior has a good balance between elasticity and adhesion, and is in a flow jelly state having fluidity, so that it undergoes large deformation with a small stress. The value of the mechanical tangent loss tan δ is in a range (0.1 to 1) in which the bolus is in a state suitable for swallowing. Even if the ratio (weight ratio) of xanthan gum and tara gum, the ratio of thickening polysaccharide (weight basis) is changed, the value of tan δ is hardly changed, as the crosslinking density between both gum molecular chains changes. Although the value of the storage elastic modulus G ′ changes, it seems that the qualitative properties of the cross-linking points (mainly hydrogen bonds) of the three-dimensional network structure do not change.
実施例7〜10
実施例1〜4で調製したそれぞれの嚥下食の貯蔵弾性率G’、変形率を25℃で測定し、両者の関係を図2に示す。
Examples 7-10
The storage elastic modulus G ′ and deformation rate of each swallowed meal prepared in Examples 1 to 4 were measured at 25 ° C., and the relationship between them is shown in FIG.
図2において、貯蔵弾性率G’は、変形率30〜40%で急激に減少する。この挙動は、ひずみの増加に伴って、壊れにくい強い結合までが壊れ始めるためと推定される。減少する程度は、キサンタンガムとタラガムとの割合(重量比)及び増粘多糖類の割合(重量基準)に影響を受ける。また、貯蔵弾性率G’は、キサンタンガム/タラガム(重量比)が80/20、30/70、40/60の順に大きく減少するが、このような挙動は、ゲルの三次元網目構造の架橋密度の大きさに対応し、架橋密度が大きいほど、貯蔵弾性率G’が大きくなり、また、貯蔵弾性率G’も大きく減少するようである。 In FIG. 2, the storage elastic modulus G ′ rapidly decreases at a deformation rate of 30 to 40%. This behavior is presumed to be due to the fact that even strong bonds that are hard to break begin to break with increasing strain. The degree of reduction is affected by the ratio (weight ratio) of xanthan gum and tara gum and the ratio of thickening polysaccharide (weight basis). In addition, the storage elastic modulus G ′ greatly decreases in the order of xanthan gum / tara gum (weight ratio) of 80/20, 30/70, and 40/60, and such behavior is caused by the crosslinking density of the three-dimensional network structure of the gel. The storage elastic modulus G ′ increases and the storage elastic modulus G ′ seems to decrease greatly as the crosslinking density increases.
実施例11〜14
実施例1、3、2及び4で調製した嚥下食の貯蔵弾性率G’と温度との関係(貯蔵弾性率G’の温度依存性)を図3に示す。なお、貯蔵弾性率G’と温度との関係は、周波数を1Hzに固定し、測定温度25℃から1分間2℃の割合で昇温して貯蔵弾性率G’を測定した。
Examples 11-14
FIG. 3 shows the relationship between the storage elastic modulus G ′ of swallowed foods prepared in Examples 1, 3, 2, and 4 and the temperature (temperature dependence of the storage elastic modulus G ′). The relationship between the storage elastic modulus G ′ and the temperature was measured by fixing the frequency at 1 Hz and increasing the temperature at a rate of 2 ° C. for 1 minute from the measurement temperature of 25 ° C. to measure the storage elastic modulus G ′.
実施例15
実施例14で調製した嚥下食の貯蔵弾性率G’と温度との関係を測定した後、昇温された嚥下食を放冷し、さらに一昼夜、冷凍庫で放置した。凍結した嚥下食を解凍した後、再度、貯蔵弾性率G’と温度との関係を測定した。結果を図3に示す。
Example 15
After measuring the relationship between the storage elastic modulus G ′ of the swallowed food prepared in Example 14 and the temperature, the swallowed food heated was allowed to cool and left in the freezer overnight. After thawing the frozen swallowing meal, the relationship between storage elastic modulus G ′ and temperature was measured again. The results are shown in FIG.
なお、図3の記号a〜dは、貯蔵弾性率G’が急激に変化する点を示し、記号aは実施例11の嚥下食、記号bは実施例12の嚥下食、記号cは実施例13の嚥下食、記号dは実施例14の嚥下食を示す。図3において、増粘多糖類が0.4重量部(実施例11〜13)のとき、貯蔵弾性率G’が大きく変化する温度は、キサンタンガム/タラガム(重量比)が40/60の場合で、ほぼ38℃であり、以下、30/70、80/20の順に低くなる。増粘多糖類が0.5重量部(実施例14)のとき、貯蔵弾性率G’が大きく変化する温度は、ほぼ43℃である。以上の結果から、貯蔵弾性率G’が大きく変化する温度は、ゲルの三次元網目構造の架橋密度の大きさに影響を受け、架橋密度が大きいほど貯蔵弾性率G’が大きく変化する温度が高くなるようである。貯蔵弾性率G’が急激に変化した温度より高温領域で、貯蔵弾性率G’の温度依存性の挙動が大きく違うのは、ゲルの融解過程におけるキサンタンガムとタラガムとの量的比率に差異があるためであり、この差異が、キサンタンガムとタラガムの両者の粘弾性挙動に影響を与えるようである。また、実施例15において、得られた嚥下食を凍結融解した後、再度、貯蔵弾性率G’と温度との関係を測定したところ、凍結融解の前後での挙動の差異はほとんど見られず、本発明の嚥下食は、凍結融解を行っても、離水してパサつき感が出ない、即ち、凍結耐性(耐凍結安定性)を有すると言える。 The symbols a to d in FIG. 3 indicate points where the storage elastic modulus G ′ changes abruptly, the symbol a is the swallowing meal of Example 11, the symbol b is the swallowing meal of Example 12, and the symbol c is the example. 13 swallowing meals, symbol d indicates the swallowing meal of Example 14. In FIG. 3, when the thickening polysaccharide is 0.4 parts by weight (Examples 11 to 13), the temperature at which the storage elastic modulus G ′ changes greatly is when xanthan gum / tara gum (weight ratio) is 40/60. The temperature is approximately 38 ° C., and decreases in the order of 30/70 and 80/20. When the thickening polysaccharide is 0.5 parts by weight (Example 14), the temperature at which the storage elastic modulus G ′ changes greatly is approximately 43 ° C. From the above results, the temperature at which the storage elastic modulus G ′ changes greatly is affected by the crosslink density of the three-dimensional network structure of the gel, and the temperature at which the storage elastic modulus G ′ changes greatly as the crosslink density increases. Seems to be higher. The temperature-dependent behavior of the storage elastic modulus G ′ is greatly different in a region higher than the temperature at which the storage elastic modulus G ′ has suddenly changed. This is because the quantitative ratio between xanthan gum and tara gum in the melting process of the gel is different. This difference seems to affect the viscoelastic behavior of both xanthan gum and tara gum. Further, in Example 15, after freezing and thawing the obtained swallow food, again measuring the relationship between the storage elastic modulus G ′ and the temperature, almost no difference in behavior before and after freezing and thawing, It can be said that the swallowing food of the present invention does not give a feeling of dryness even after freezing and thawing, that is, it has freezing resistance (freezing stability).
Claims (21)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2006314063A JP2008125435A (en) | 2006-11-21 | 2006-11-21 | Gel-forming composition, and gel containing composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2006314063A JP2008125435A (en) | 2006-11-21 | 2006-11-21 | Gel-forming composition, and gel containing composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2008125435A true JP2008125435A (en) | 2008-06-05 |
Family
ID=39551900
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006314063A Pending JP2008125435A (en) | 2006-11-21 | 2006-11-21 | Gel-forming composition, and gel containing composition |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2008125435A (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101317691B1 (en) * | 2012-02-09 | 2013-10-15 | 강릉원주대학교산학협력단 | A method for preparing the salted Alaska pollack roe using by sea mustard oil |
| JP2014166154A (en) * | 2013-02-28 | 2014-09-11 | Orihiro Plantdew Kk | Pasty honey and method for producing the same |
| JP2014530855A (en) * | 2011-10-19 | 2014-11-20 | アール.ピー. シェーラーテクノロジーズ エルエルシー | Two-phase drug delivery system |
| US9050357B2 (en) | 2010-03-08 | 2015-06-09 | Cp Kelco U.S., Inc. | Compositions and methods for producing consumables for patients with dysphagia |
| CN114514292A (en) * | 2019-08-29 | 2022-05-17 | 法国比克公司 | Preparation method of aqueous gel ink containing gold nanoparticles and having fixed color |
| JP2023051182A (en) * | 2021-09-30 | 2023-04-11 | キヤノン株式会社 | Ultrasonic phantom and manufacturing method of ultrasonic phantom |
-
2006
- 2006-11-21 JP JP2006314063A patent/JP2008125435A/en active Pending
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9050357B2 (en) | 2010-03-08 | 2015-06-09 | Cp Kelco U.S., Inc. | Compositions and methods for producing consumables for patients with dysphagia |
| JP2014530855A (en) * | 2011-10-19 | 2014-11-20 | アール.ピー. シェーラーテクノロジーズ エルエルシー | Two-phase drug delivery system |
| KR101317691B1 (en) * | 2012-02-09 | 2013-10-15 | 강릉원주대학교산학협력단 | A method for preparing the salted Alaska pollack roe using by sea mustard oil |
| JP2014166154A (en) * | 2013-02-28 | 2014-09-11 | Orihiro Plantdew Kk | Pasty honey and method for producing the same |
| CN114514292A (en) * | 2019-08-29 | 2022-05-17 | 法国比克公司 | Preparation method of aqueous gel ink containing gold nanoparticles and having fixed color |
| CN114514292B (en) * | 2019-08-29 | 2023-08-11 | 法国比克公司 | Preparation method of aqueous gel ink with fixed color comprising gold nanoparticles |
| US11820905B2 (en) | 2019-08-29 | 2023-11-21 | Societe Bic | Process of preparation of an aqueous gel ink with fixed color comprising gold nanoparticles |
| JP2023051182A (en) * | 2021-09-30 | 2023-04-11 | キヤノン株式会社 | Ultrasonic phantom and manufacturing method of ultrasonic phantom |
| JP7749397B2 (en) | 2021-09-30 | 2025-10-06 | キヤノン株式会社 | Ultrasound phantom and method for manufacturing the ultrasound phantom |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1874690B (en) | Satiety enhancing food compositions | |
| CN103262992B (en) | Purple sweet potato milk pudding and processing method thereof | |
| JP5184257B2 (en) | Beverages containing eggshell membrane powder | |
| CN103200829B (en) | Powder mixture | |
| JP6724104B2 (en) | Foods containing barley powder | |
| JP6166428B2 (en) | Smoothie with ground konjac | |
| JP4352205B2 (en) | Swallowing food composition and evaluation method thereof | |
| JP2004283073A (en) | Food for persons with difficulty in digestion or swallowing, and digestion or swallowing auxiliary composition | |
| JP2008099670A (en) | Gel-forming composition and gel using the composition | |
| JP2004350680A (en) | Gelling agent composition and gelatinous composition for food suitable for person with ingestion/swallowing difficulty | |
| JP2004350679A (en) | Gelling agent composition and gelatinous composition for food suitable for person with ingestion/swallowing difficulty | |
| CN106136218A (en) | A kind of preparation method of Se-enriched Icing Sugar | |
| JPS63269993A (en) | Foods containing partially degraded indigestible polysaccharides | |
| JP5089650B2 (en) | Acid gel food | |
| CN106954796A (en) | A kind of cereal egg milk pudding and preparation method thereof | |
| JP4484759B2 (en) | High protein gel food | |
| JP2008125435A (en) | Gel-forming composition, and gel containing composition | |
| JP2004344165A (en) | Easily soluble powder composition | |
| JP2014103896A (en) | Acidic gelatinous food product | |
| EP1008306B1 (en) | Polysaccharide which can reduce viscosity resulting from psyllium, and foods containing the polysaccharide and psyllium | |
| JP2013208103A (en) | Regular diet-like jelly-in-jelly | |
| JPH02154673A (en) | Method for producing a beverage containing water-soluble dietary fiber | |
| JP3637852B2 (en) | Konjac food and production method | |
| JP5839924B2 (en) | Acid gel food | |
| JP4589251B2 (en) | Powder granulation method and easily soluble granule composition |